<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="PMC1557711%20Table%201_files/filelist.xml">
<link rel=Edit-Time-Data href="PMC1557711%20Table%201_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<link rel=themeData href="PMC1557711%20Table%201_files/themedata.thmx">
<link rel=colorSchemeMapping
href="PMC1557711%20Table%201_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>96</w:Zoom>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SplitPgBreakAndParaMark/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:inherit;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
h2
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:13.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
h4
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 2";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 4";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.ui-button, li.ui-button, div.ui-button
	{mso-style-name:ui-button;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:1.2pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner, li.ui-spinner, div.ui-spinner
	{mso-style-name:ui-spinner;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner-input, li.ui-spinner-input, div.ui-spinner-input
	{mso-style-name:ui-spinner-input;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:16.5pt;
	margin-bottom:2.4pt;
	margin-left:4.8pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-hidden-accessible, li.ui-helper-hidden-accessible, div.ui-helper-hidden-accessible
	{mso-style-name:ui-helper-hidden-accessible;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-buttonset, li.ui-buttonset, div.ui-buttonset
	{mso-style-name:ui-buttonset;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:5.25pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker, li.ui-datepicker, div.ui-datepicker
	{mso-style-name:ui-datepicker;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-datepicker-row-break, li.ui-datepicker-row-break, div.ui-datepicker-row-break
	{mso-style-name:ui-datepicker-row-break;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-rtl, li.ui-datepicker-rtl, div.ui-datepicker-rtl
	{mso-style-name:ui-datepicker-rtl;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	direction:rtl;
	unicode-bidi:embed;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu, li.ui-menu, div.ui-menu
	{mso-style-name:ui-menu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar, li.ui-progressbar, div.ui-progressbar
	{mso-style-name:ui-progressbar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-handle, li.ui-resizable-handle, div.ui-resizable-handle
	{mso-style-name:ui-resizable-handle;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-n, li.ui-resizable-n, div.ui-resizable-n
	{mso-style-name:ui-resizable-n;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-s, li.ui-resizable-s, div.ui-resizable-s
	{mso-style-name:ui-resizable-s;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-e, li.ui-resizable-e, div.ui-resizable-e
	{mso-style-name:ui-resizable-e;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-w, li.ui-resizable-w, div.ui-resizable-w
	{mso-style-name:ui-resizable-w;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-se, li.ui-resizable-se, div.ui-resizable-se
	{mso-style-name:ui-resizable-se;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-sw, li.ui-resizable-sw, div.ui-resizable-sw
	{mso-style-name:ui-resizable-sw;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-nw, li.ui-resizable-nw, div.ui-resizable-nw
	{mso-style-name:ui-resizable-nw;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-ne, li.ui-resizable-ne, div.ui-resizable-ne
	{mso-style-name:ui-resizable-ne;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectable-helper, li.ui-selectable-helper, div.ui-selectable-helper
	{mso-style-name:ui-selectable-helper;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-menu, li.ui-selectmenu-menu, div.ui-selectmenu-menu
	{mso-style-name:ui-selectmenu-menu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-selectmenu-open, li.ui-selectmenu-open, div.ui-selectmenu-open
	{mso-style-name:ui-selectmenu-open;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-button, li.ui-selectmenu-button, div.ui-selectmenu-button
	{mso-style-name:ui-selectmenu-button;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider, li.ui-slider, div.ui-slider
	{mso-style-name:ui-slider;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-horizontal, li.ui-slider-horizontal, div.ui-slider-horizontal
	{mso-style-name:ui-slider-horizontal;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-vertical, li.ui-slider-vertical, div.ui-slider-vertical
	{mso-style-name:ui-slider-vertical;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner-button, li.ui-spinner-button, div.ui-spinner-button
	{mso-style-name:ui-spinner-button;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:6.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tooltip, li.ui-tooltip, div.ui-tooltip
	{mso-style-name:ui-tooltip;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-default, li.ui-state-default, div.ui-state-default
	{mso-style-name:ui-state-default;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-focus, li.ui-state-focus, div.ui-state-focus
	{mso-style-name:ui-state-focus;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover, li.ui-state-hover, div.ui-state-hover
	{mso-style-name:ui-state-hover;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active, li.ui-state-active, div.ui-state-active
	{mso-style-name:ui-state-active;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-highlight, li.ui-state-highlight, div.ui-state-highlight
	{mso-style-name:ui-state-highlight;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-error, li.ui-state-error, div.ui-state-error
	{mso-style-name:ui-state-error;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text, li.ui-state-error-text, div.ui-state-error-text
	{mso-style-name:ui-state-error-text;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-priority-primary, li.ui-priority-primary, div.ui-priority-primary
	{mso-style-name:ui-priority-primary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-secondary, li.ui-priority-secondary, div.ui-priority-secondary
	{mso-style-name:ui-priority-secondary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled, li.ui-state-disabled, div.ui-state-disabled
	{mso-style-name:ui-state-disabled;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-hidden, li.ui-helper-hidden, div.ui-helper-hidden
	{mso-style-name:ui-helper-hidden;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-helper-reset, li.ui-helper-reset, div.ui-helper-reset
	{mso-style-name:ui-helper-reset;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-zfix, li.ui-helper-zfix, div.ui-helper-zfix
	{mso-style-name:ui-helper-zfix;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget-overlay, li.ui-widget-overlay, div.ui-widget-overlay
	{mso-style-name:ui-widget-overlay;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-clearfix, li.ui-helper-clearfix, div.ui-helper-clearfix
	{mso-style-name:ui-helper-clearfix;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon, li.ui-icon, div.ui-icon
	{mso-style-name:ui-icon;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget-content, li.ui-widget-content, div.ui-widget-content
	{mso-style-name:ui-widget-content;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#222222;}
p.ui-widget-header, li.ui-widget-header, div.ui-widget-header
	{mso-style-name:ui-widget-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#CCCCCC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#222222;
	font-weight:bold;}
p.ui-widget-shadow, li.ui-widget-shadow, div.ui-widget-shadow
	{mso-style-name:ui-widget-shadow;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:-6.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget, li.ui-widget, div.ui-widget
	{mso-style-name:ui-widget;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs, li.ui-tabs, div.ui-tabs
	{mso-style-name:ui-tabs;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog, li.ui-dialog, div.ui-dialog
	{mso-style-name:ui-dialog;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-titlebar, li.ui-dialog-titlebar, div.ui-dialog-titlebar
	{mso-style-name:ui-dialog-titlebar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.ui-ncbiautocomplete-actions, li.ui-ncbiautocomplete-actions, div.ui-ncbiautocomplete-actions
	{mso-style-name:ui-ncbiautocomplete-actions;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:.75pt;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#CECECE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref, li.ui-ncbiautocomplete-link-pref, div.ui-ncbiautocomplete-link-pref
	{mso-style-name:ui-ncbiautocomplete-link-pref;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:-945.65pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton, li.ui-ncbibutton, div.ui-ncbibutton
	{mso-style-name:ui-ncbibutton;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:1.2pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"inherit","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
p.ui-button-icon-only, li.ui-button-icon-only, div.ui-button-icon-only
	{mso-style-name:ui-button-icon-only;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icons-only, li.ui-button-icons-only, div.ui-button-icons-only
	{mso-style-name:ui-button-icons-only;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-outer-div, li.ui-ncbigrid-outer-div, div.ui-ncbigrid-outer-div
	{mso-style-name:ui-ncbigrid-outer-div;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:33.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-inner-div, li.ui-ncbigrid-inner-div, div.ui-ncbigrid-inner-div
	{mso-style-name:ui-ncbigrid-inner-div;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-filter-toolbar, li.ui-ncbigrid-filter-toolbar, div.ui-ncbigrid-filter-toolbar
	{mso-style-name:ui-ncbigrid-filter-toolbar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	line-height:20.25pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-toolbar, li.ui-ncbigrid-paged-toolbar, div.ui-ncbigrid-paged-toolbar
	{mso-style-name:ui-ncbigrid-paged-toolbar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:19.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-checkbox-toolbar, li.ui-ncbigrid-checkbox-toolbar, div.ui-ncbigrid-checkbox-toolbar
	{mso-style-name:ui-ncbigrid-checkbox-toolbar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:21.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-countitems, li.ui-ncbigrid-paged-countitems, div.ui-ncbigrid-paged-countitems
	{mso-style-name:ui-ncbigrid-paged-countitems;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-pagecontrol, li.ui-ncbigrid-paged-pagecontrol, div.ui-ncbigrid-paged-pagecontrol
	{mso-style-name:ui-ncbigrid-paged-pagecontrol;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-toolbar-bottom, li.ui-ncbigrid-paged-toolbar-bottom, div.ui-ncbigrid-paged-toolbar-bottom
	{mso-style-name:ui-ncbigrid-paged-toolbar-bottom;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-question, li.ui-ncbigrid-select-question, div.ui-ncbigrid-select-question
	{mso-style-name:ui-ncbigrid-select-question;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbigrid-select-question-footer, li.ui-ncbigrid-select-question-footer, div.ui-ncbigrid-select-question-footer
	{mso-style-name:ui-ncbigrid-select-question-footer;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenu, li.ui-ncbibasicmenu, div.ui-ncbibasicmenu
	{mso-style-name:ui-ncbibasicmenu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenuli, li.ui-ncbibasicmenuli, div.ui-ncbibasicmenuli
	{mso-style-name:ui-ncbibasicmenu>li;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.orientationhortli, li.orientationhortli, div.orientationhortli
	{mso-style-name:orientation_hort>li;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbimenu, li.jig-ncbimenu, div.jig-ncbimenu
	{mso-style-name:jig-ncbimenu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbimenuli, li.jig-ncbimenuli, div.jig-ncbimenuli
	{mso-style-name:jig-ncbimenu>li;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbipopper-wrapper, li.ui-ncbipopper-wrapper, div.ui-ncbipopper-wrapper
	{mso-style-name:ui-ncbipopper-wrapper;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbipopper-basic, li.ui-ncbipopper-basic, div.ui-ncbipopper-basic
	{mso-style-name:ui-ncbipopper-basic;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#303030;}
p.brieflinkpopdesc, li.brieflinkpopdesc, div.brieflinkpopdesc
	{mso-style-name:brieflinkpopdesc;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:4.8pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbitoggler-slave, li.ui-ncbitoggler-slave, div.ui-ncbitoggler-slave
	{mso-style-name:ui-ncbitoggler-slave;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbitoggler-slave-open, li.ui-ncbitoggler-slave-open, div.ui-ncbitoggler-slave-open
	{mso-style-name:ui-ncbitoggler-slave-open;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbilinksmenu, li.ui-ncbilinksmenu, div.ui-ncbilinksmenu
	{mso-style-name:ui-ncbilinksmenu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FCFCFC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#999999;
	font-weight:bold;}
p.ui-ncbilinksmenu-loadingmessage, li.ui-ncbilinksmenu-loadingmessage, div.ui-ncbilinksmenu-loadingmessage
	{mso-style-name:ui-ncbilinksmenu-loadingmessage;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiclearbutton-wrap, li.ui-ncbiclearbutton-wrap, div.ui-ncbiclearbutton-wrap
	{mso-style-name:ui-ncbiclearbutton-wrap;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiexpander, li.ui-ncbiexpander, div.ui-ncbiexpander
	{mso-style-name:ui-ncbiexpander;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiexpander-simple, li.ui-ncbiexpander-simple, div.ui-ncbiexpander-simple
	{mso-style-name:ui-ncbiexpander-simple;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-expander-arrow-bar, li.ui-expander-arrow-bar, div.ui-expander-arrow-bar
	{mso-style-name:ui-expander-arrow-bar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-expander-controllink, li.ui-expander-controllink, div.ui-expander-controllink
	{mso-style-name:ui-expander-controllink;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbiinpagenav-goto-container, li.jig-ncbiinpagenav-goto-container, div.jig-ncbiinpagenav-goto-container
	{mso-style-name:jig-ncbiinpagenav-goto-container;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch, li.ui-ncbisetswitch, div.ui-ncbisetswitch
	{mso-style-name:ui-ncbisetswitch;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;}
p.ui-ncbisetswitch-hasstar, li.ui-ncbisetswitch-hasstar, div.ui-ncbisetswitch-hasstar
	{mso-style-name:ui-ncbisetswitch-hasstar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fg-button-icon-left, li.fg-button-icon-left, div.fg-button-icon-left
	{mso-style-name:fg-button-icon-left;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbihistogram, li.jig-ncbihistogram, div.jig-ncbihistogram
	{mso-style-name:jig-ncbihistogram;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram, li.ui-ncbihistogram, div.ui-ncbihistogram
	{mso-style-name:ui-ncbihistogram;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-display-area, li.ui-ncbihistogram-display-area, div.ui-ncbihistogram-display-area
	{mso-style-name:ui-ncbihistogram-display-area;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-display-areaollih3, li.ui-ncbihistogram-display-areaollih3, div.ui-ncbihistogram-display-areaollih3
	{mso-style-name:ui-ncbihistogram-display-area>ol>li>h3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:366.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-controls, li.ui-ncbihistogram-controls, div.ui-ncbihistogram-controls
	{mso-style-name:ui-ncbihistogram-controls;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-left, li.ui-ncbihistogram-left, div.ui-ncbihistogram-left
	{mso-style-name:ui-ncbihistogram-left;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:2.25pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-right, li.ui-ncbihistogram-right, div.ui-ncbihistogram-right
	{mso-style-name:ui-ncbihistogram-right;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:2.25pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-left-disabled, li.ui-ncbihistogram-left-disabled, div.ui-ncbihistogram-left-disabled
	{mso-style-name:ui-ncbihistogram-left-disabled;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#DDDDDD;}
p.ui-ncbihistogram-right-disabled, li.ui-ncbihistogram-right-disabled, div.ui-ncbihistogram-right-disabled
	{mso-style-name:ui-ncbihistogram-right-disabled;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#DDDDDD;}
p.ui-ncbihistogram-text, li.ui-ncbihistogram-text, div.ui-ncbihistogram-text
	{mso-style-name:ui-ncbihistogram-text;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:12.75pt;
	margin-bottom:0in;
	margin-left:12.75pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.8pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-tooltip, li.ui-ncbihistogram-tooltip, div.ui-ncbihistogram-tooltip
	{mso-style-name:ui-ncbihistogram-tooltip;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	display:none;
	mso-hide:all;}
p.ncbiactivevalidationmsg, li.ncbiactivevalidationmsg, div.ncbiactivevalidationmsg
	{mso-style-name:ncbiactivevalidation_msg;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ncbiactivevalidationmsgchecking, li.ncbiactivevalidationmsgchecking, div.ncbiactivevalidationmsgchecking
	{mso-style-name:ncbiactivevalidation_msg_checking;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#FF9900;}
p.ncbiactivevalidationmsgvalid, li.ncbiactivevalidationmsgvalid, div.ncbiactivevalidationmsgvalid
	{mso-style-name:ncbiactivevalidation_msg_valid;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:green;}
p.ncbiactivevalidationmsgerror, li.ncbiactivevalidationmsgerror, div.ncbiactivevalidationmsgerror
	{mso-style-name:ncbiactivevalidation_msg_error;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.ncbiactivevalidationmsginfo, li.ncbiactivevalidationmsginfo, div.ncbiactivevalidationmsginfo
	{mso-style-name:ncbiactivevalidation_msg_info;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:blue;}
p.ncbiactivevalidationelerror, li.ncbiactivevalidationelerror, div.ncbiactivevalidationelerror
	{mso-style-name:ncbiactivevalidation_el_error;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.social-buttons, li.social-buttons, div.social-buttons
	{mso-style-name:social-buttons;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.inlinelist, li.inlinelist, div.inlinelist
	{mso-style-name:inline_list;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.inline, li.inline, div.inline
	{mso-style-name:inline;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fig, li.fig, div.fig
	{mso-style-name:fig;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.table, li.table, div.table
	{mso-style-name:table;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pmc-wm, li.pmc-wm, div.pmc-wm
	{mso-style-name:pmc-wm;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.attic, li.attic, div.attic
	{mso-style-name:attic;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.basement, li.basement, div.basement
	{mso-style-name:basement;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-breadcrumbs, li.page-breadcrumbs, div.page-breadcrumbs
	{mso-style-name:page-breadcrumbs;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.first-line-outdent, li.first-line-outdent, div.first-line-outdent
	{mso-style-name:first-line-outdent;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vatop, li.vatop, div.vatop
	{mso-style-name:va_top;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vamiddle, li.vamiddle, div.vamiddle
	{mso-style-name:va_middle;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.qtrhythm, li.qtrhythm, div.qtrhythm
	{mso-style-name:qt_rhythm;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:4.15pt;
	margin-right:0in;
	margin-bottom:4.15pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notopmargin, li.notopmargin, div.notopmargin
	{mso-style-name:no_top_margin;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nobottommargin, li.nobottommargin, div.nobottommargin
	{mso-style-name:no_bottom_margin;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tscanvas, li.tscanvas, div.tscanvas
	{mso-style-name:ts_canvas;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tsbar, li.tsbar, div.tsbar
	{mso-style-name:ts_bar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#DCF0F4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-reuse, li.fm-reuse, div.fm-reuse
	{mso-style-name:fm-reuse;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:.5in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-subtitle, li.fm-subtitle, div.fm-subtitle
	{mso-style-name:fm-subtitle;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:15.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-copyright-license, li.fm-copyright-license, div.fm-copyright-license
	{mso-style-name:fm-copyright-license;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-citation-from, li.fm-citation-from, div.fm-citation-from
	{mso-style-name:fm-citation-from;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ft-thumb-box, li.ft-thumb-box, div.ft-thumb-box
	{mso-style-name:ft-thumb-box;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:8.3pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ft-thumb-current, li.ft-thumb-current, div.ft-thumb-current
	{mso-style-name:ft-thumb-current;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#D0DCE8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tab, li.tab, div.tab
	{mso-style-name:tab;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arrowtab, li.arrowtab, div.arrowtab
	{mso-style-name:arrowtab;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.blanktab, li.blanktab, div.blanktab
	{mso-style-name:blanktab;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.thistab, li.thistab, div.thistab
	{mso-style-name:thistab;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.doi, li.doi, div.doi
	{mso-style-name:doi;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.msg-error, li.msg-error, div.msg-error
	{mso-style-name:msg-error;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.msg-warning, li.msg-warning, div.msg-warning
	{mso-style-name:msg-warning;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:brown;}
p.nihms-highlight, li.nihms-highlight, div.nihms-highlight
	{mso-style-name:nihms-highlight;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:2.4pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:10.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#990000;}
p.head, li.head, div.head
	{mso-style-name:head;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sub-head, li.sub-head, div.sub-head
	{mso-style-name:sub-head;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.headless, li.headless, div.headless
	{mso-style-name:headless;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sub-navigation, li.sub-navigation, div.sub-navigation
	{mso-style-name:sub-navigation;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sec, li.sec, div.sec
	{mso-style-name:sec;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content-branding, li.content-branding, div.content-branding
	{mso-style-name:content-branding;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-generic-logo-background, li.banner-generic-logo-background, div.banner-generic-logo-background
	{mso-style-name:banner-generic-logo-background;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:silver;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.banner-journal-name, li.banner-journal-name, div.banner-journal-name
	{mso-style-name:banner-journal-name;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:20.5pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	letter-spacing:.3pt;}
p.banner-journal-publisher-over-image, li.banner-journal-publisher-over-image, div.banner-journal-publisher-over-image
	{mso-style-name:banner-journal-publisher-over-image;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:7.5pt;
	mso-margin-bottom-alt:auto;
	margin-left:63.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-publisher-name, li.banner-publisher-name, div.banner-publisher-name
	{mso-style-name:banner-publisher-name;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:9.5pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	color:#AA1111;
	font-weight:bold;}
p.bl-w-jtitle-over, li.bl-w-jtitle-over, div.bl-w-jtitle-over
	{mso-style-name:bl-w-jtitle-over;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-variant:small-caps;}
p.bl-w-jtitle-over-ph, li.bl-w-jtitle-over-ph, div.bl-w-jtitle-over-ph
	{mso-style-name:bl-w-jtitle-over-ph;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-w-jtitle-over-ph-content, li.bl-w-jtitle-over-ph-content, div.bl-w-jtitle-over-ph-content
	{mso-style-name:bl-w-jtitle-over-ph-content;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:3.0pt;
	margin-right:6.0pt;
	margin-bottom:3.0pt;
	margin-left:78.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-journal-publisher-over-image-elsevierwt, li.banner-journal-publisher-over-image-elsevierwt, div.banner-journal-publisher-over-image-elsevierwt
	{mso-style-name:banner-journal-publisher-over-image-elsevierwt;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:120.0pt;
	margin-bottom:0in;
	margin-left:15.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.elsevierwt-sponsored-label, li.elsevierwt-sponsored-label, div.elsevierwt-sponsored-label
	{mso-style-name:elsevierwt-sponsored-label;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-9.0pt;
	line-height:13.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	letter-spacing:.9pt;
	font-style:italic;}
p.bl-jtitle-sageopen, li.bl-jtitle-sageopen, div.bl-jtitle-sageopen
	{mso-style-name:bl-jtitle-sageopen;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#0055A5;}
p.bl-jtitle-iospressopenlib, li.bl-jtitle-iospressopenlib, div.bl-jtitle-iospressopenlib
	{mso-style-name:bl-jtitle-iospressopenlib;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-apasd, li.bl-jtitle-apasd, div.bl-jtitle-apasd
	{mso-style-name:bl-jtitle-apasd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#1E73B3;}
p.bl-jtitle-springeropen, li.bl-jtitle-springeropen, div.bl-jtitle-springeropen
	{mso-style-name:bl-jtitle-springeropen;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.bl-jtitle-sfesd, li.bl-jtitle-sfesd, div.bl-jtitle-sfesd
	{mso-style-name:bl-jtitle-sfesd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-acssd, li.bl-jtitle-acssd, div.bl-jtitle-acssd
	{mso-style-name:bl-jtitle-acssd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#1E73B3;}
p.bl-jtitle-esesd, li.bl-jtitle-esesd, div.bl-jtitle-esesd
	{mso-style-name:bl-jtitle-esesd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:33.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-jtitle-srfsd, li.bl-jtitle-srfsd, div.bl-jtitle-srfsd
	{mso-style-name:bl-jtitle-srfsd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:33.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-jtitle-tea, li.bl-jtitle-tea, div.bl-jtitle-tea
	{mso-style-name:bl-jtitle-tea;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#861316;}
p.bl-jtitle-rcpsychsd, li.bl-jtitle-rcpsychsd, div.bl-jtitle-rcpsychsd
	{mso-style-name:bl-jtitle-rcpsychsd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#44448A;}
p.bl-jtitle-npgopen, li.bl-jtitle-npgopen, div.bl-jtitle-npgopen
	{mso-style-name:bl-jtitle-npgopen;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-maneyopen, li.bl-jtitle-maneyopen, div.bl-jtitle-maneyopen
	{mso-style-name:bl-jtitle-maneyopen;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-bmjgroup, li.bl-jtitle-bmjgroup, div.bl-jtitle-bmjgroup
	{mso-style-name:bl-jtitle-bmjgroup;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#003366;}
p.bl-jtitle-clpt, li.bl-jtitle-clpt, div.bl-jtitle-clpt
	{mso-style-name:bl-jtitle-clpt;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-nihpa-wiley, li.bl-jtitle-nihpa-wiley, div.bl-jtitle-nihpa-wiley
	{mso-style-name:bl-jtitle-nihpa-wiley;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-rsmsd, li.bl-jtitle-rsmsd, div.bl-jtitle-rsmsd
	{mso-style-name:bl-jtitle-rsmsd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-hogrefesd, li.bl-jtitle-hogrefesd, div.bl-jtitle-hogrefesd
	{mso-style-name:bl-jtitle-hogrefesd;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#025490;}
p.mp-outer, li.mp-outer, div.mp-outer
	{mso-style-name:mp-outer;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mp-outerdiv, li.mp-outerdiv, div.mp-outerdiv
	{mso-style-name:mp-outer>div;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-highlight1, li.toc-highlight1, div.toc-highlight1
	{mso-style-name:toc-highlight1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FFFFD0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-highlight2, li.toc-highlight2, div.toc-highlight2
	{mso-style-name:toc-highlight2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#ACE4FF;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-hl-inaugural, li.toc-hl-inaugural, div.toc-hl-inaugural
	{mso-style-name:toc-hl-inaugural;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#E64A00;}
p.courtesy-note, li.courtesy-note, div.courtesy-note
	{mso-style-name:courtesy-note;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.footer, li.footer, div.footer
	{mso-style-name:footer;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.suppmat, li.suppmat, div.suppmat
	{mso-style-name:suppmat;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:8.3pt;
	margin-right:0in;
	margin-bottom:8.3pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.aligncenter, li.aligncenter, div.aligncenter
	{mso-style-name:align_center;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mul-switcher, li.mul-switcher, div.mul-switcher
	{mso-style-name:mul-switcher;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.strong, li.strong, div.strong
	{mso-style-name:strong;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.red, li.red, div.red
	{mso-style-name:red;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.navigator, li.navigator, div.navigator
	{mso-style-name:navigator;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.summary, li.summary, div.summary
	{mso-style-name:summary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.head1a, li.head1a, div.head1a
	{mso-style-name:head1a;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-header, li.navigator-header, div.navigator-header
	{mso-style-name:navigator-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-footer, li.navigator-footer, div.navigator-footer
	{mso-style-name:navigator-footer;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:7.5pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-bar, li.navigator-bar, div.navigator-bar
	{mso-style-name:navigator-bar;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-page, li.navigator-page, div.navigator-page
	{mso-style-name:navigator-page;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-bar-table, li.navigator-bar-table, div.navigator-bar-table
	{mso-style-name:navigator-bar-table;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.section-with-images-on-the-same-page, li.section-with-images-on-the-same-page, div.section-with-images-on-the-same-page
	{mso-style-name:section-with-images-on-the-same-page;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.main-archive-list-of-volumes, li.main-archive-list-of-volumes, div.main-archive-list-of-volumes
	{mso-style-name:main-archive-list-of-volumes;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.archive-header, li.archive-header, div.archive-header
	{mso-style-name:archive-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:7.5pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.journal-block-title, li.journal-block-title, div.journal-block-title
	{mso-style-name:journal-block-title;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	font-weight:bold;}
p.vol-year-cell, li.vol-year-cell, div.vol-year-cell
	{mso-style-name:vol-year-cell;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	font-weight:bold;}
p.issue-block, li.issue-block, div.issue-block
	{mso-style-name:issue-block;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#8CACCC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-dark-row, li.iss-dark-row, div.iss-dark-row
	{mso-style-name:iss-dark-row;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#EFF1F3;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-light-row, li.iss-light-row, div.iss-light-row
	{mso-style-name:iss-light-row;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-cell, li.iss-cell, div.iss-cell
	{mso-style-name:iss-cell;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vol-cell, li.vol-cell, div.vol-cell
	{mso-style-name:vol-cell;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arc-issue, li.arc-issue, div.arc-issue
	{mso-style-name:arc-issue;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#0055AA;}
p.large-thumb-canvas, li.large-thumb-canvas, div.large-thumb-canvas
	{mso-style-name:large-thumb-canvas;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:8.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;
	display:none;
	mso-hide:all;}
p.co, li.co, div.co
	{mso-style-name:co;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.co-default, li.co-default, div.co-default
	{mso-style-name:co-default;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:8.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;}
p.large-thumb-canvas-1, li.large-thumb-canvas-1, div.large-thumb-canvas-1
	{mso-style-name:large-thumb-canvas-1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.co-inner, li.co-inner, div.co-inner
	{mso-style-name:co-inner;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.in-progress, li.in-progress, div.in-progress
	{mso-style-name:in-progress;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	background:#444444;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.large-thumb, li.large-thumb, div.large-thumb
	{mso-style-name:large-thumb;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.small-thumb-canvas, li.small-thumb-canvas, div.small-thumb-canvas
	{mso-style-name:small-thumb-canvas;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.small-thumb, li.small-thumb, div.small-thumb
	{mso-style-name:small-thumb;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup-sensitive-area, li.figpopup-sensitive-area, div.figpopup-sensitive-area
	{mso-style-name:figpopup-sensitive-area;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.print-view, li.print-view, div.print-view
	{mso-style-name:print-view;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.citationexporter-header, li.citationexporter-header, div.citationexporter-header
	{mso-style-name:citationexporter-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-style:italic;}
p.citationexporter-footer, li.citationexporter-footer, div.citationexporter-footer
	{mso-style-name:citationexporter-footer;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxpreview, li.mathjaxpreview, div.mathjaxpreview
	{mso-style-name:mathjax_preview;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#888888;}
p.mathjaxerror, li.mathjaxerror, div.mathjaxerror
	{mso-style-name:mathjax_error;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CC0000;
	font-style:italic;}
p.print-log, li.print-log, div.print-log
	{mso-style-name:print-log;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxmenu, li.mathjaxmenu, div.mathjaxmenu
	{mso-style-name:mathjax_menu;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;}
p.mathjaxmenuitem, li.mathjaxmenuitem, div.mathjaxmenuitem
	{mso-style-name:mathjax_menuitem;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxmenuarrow, li.mathjaxmenuarrow, div.mathjaxmenuarrow
	{mso-style-name:mathjax_menuarrow;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","sans-serif";
	color:#666666;}
p.mathjaxmenucheck, li.mathjaxmenucheck, div.mathjaxmenucheck
	{mso-style-name:mathjax_menucheck;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Unicode MS","sans-serif";}
p.mathjaxmenulabel, li.mathjaxmenulabel, div.mathjaxmenulabel
	{mso-style-name:mathjax_menulabel;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-style:italic;}
p.mathjaxmenurule, li.mathjaxmenurule, div.mathjaxmenurule
	{mso-style-name:mathjax_menurule;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:3.0pt;
	margin-right:.75pt;
	margin-bottom:0in;
	margin-left:.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxmenuclose, li.mathjaxmenuclose, div.mathjaxmenuclose
	{mso-style-name:mathjax_menuclose;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:18.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.ui-accordion-header, li.ui-accordion-header, div.ui-accordion-header
	{mso-style-name:ui-accordion-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons, li.ui-accordion-icons, div.ui-accordion-icons
	{mso-style-name:ui-accordion-icons;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-content, li.ui-accordion-content, div.ui-accordion-content
	{mso-style-name:ui-accordion-content;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text, li.ui-button-text, div.ui-button-text
	{mso-style-name:ui-button-text;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header, li.ui-datepicker-header, div.ui-datepicker-header
	{mso-style-name:ui-datepicker-header;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-next, li.ui-datepicker-next, div.ui-datepicker-next
	{mso-style-name:ui-datepicker-next;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-prev, li.ui-datepicker-prev, div.ui-datepicker-prev
	{mso-style-name:ui-datepicker-prev;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-title, li.ui-datepicker-title, div.ui-datepicker-title
	{mso-style-name:ui-datepicker-title;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane, li.ui-datepicker-buttonpane, div.ui-datepicker-buttonpane
	{mso-style-name:ui-datepicker-buttonpane;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group, li.ui-datepicker-group, div.ui-datepicker-group
	{mso-style-name:ui-datepicker-group;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-title, li.ui-dialog-title, div.ui-dialog-title
	{mso-style-name:ui-dialog-title;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-buttonpane, li.ui-dialog-buttonpane, div.ui-dialog-buttonpane
	{mso-style-name:ui-dialog-buttonpane;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-item, li.ui-menu-item, div.ui-menu-item
	{mso-style-name:ui-menu-item;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-divider, li.ui-menu-divider, div.ui-menu-divider
	{mso-style-name:ui-menu-divider;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value, li.ui-progressbar-value, div.ui-progressbar-value
	{mso-style-name:ui-progressbar-value;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-overlay, li.ui-progressbar-overlay, div.ui-progressbar-overlay
	{mso-style-name:ui-progressbar-overlay;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle, li.ui-slider-handle, div.ui-slider-handle
	{mso-style-name:ui-slider-handle;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range, li.ui-slider-range, div.ui-slider-range
	{mso-style-name:ui-slider-range;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-nav, li.ui-tabs-nav, div.ui-tabs-nav
	{mso-style-name:ui-tabs-nav;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-panel, li.ui-tabs-panel, div.ui-tabs-panel
	{mso-style-name:ui-tabs-panel;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-hide, li.ui-tabs-hide, div.ui-tabs-hide
	{mso-style-name:ui-tabs-hide;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-titlebar-close, li.ui-dialog-titlebar-close, div.ui-dialog-titlebar-close
	{mso-style-name:ui-dialog-titlebar-close;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-content, li.ui-dialog-content, div.ui-dialog-content
	{mso-style-name:ui-dialog-content;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref-right, li.ui-ncbiautocomplete-link-pref-right, div.ui-ncbiautocomplete-link-pref-right
	{mso-style-name:ui-ncbiautocomplete-link-pref-right;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary, li.ui-button-icon-primary, div.ui-button-icon-primary
	{mso-style-name:ui-button-icon-primary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary, li.ui-button-icon-secondary, div.ui-button-icon-secondary
	{mso-style-name:ui-button-icon-secondary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.prev, li.prev, div.prev
	{mso-style-name:prev;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.next, li.next, div.next
	{mso-style-name:next;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-row-count, li.ui-ncbigrid-select-row-count, div.ui-ncbigrid-select-row-count
	{mso-style-name:ui-ncbigrid-select-row-count;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenulia, li.ui-ncbibasicmenulia, div.ui-ncbibasicmenulia
	{mso-style-name:ui-ncbibasicmenu>li>a;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbimenu-item-leaf, li.ui-ncbimenu-item-leaf, div.ui-ncbimenu-item-leaf
	{mso-style-name:ui-ncbimenu-item-leaf;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.brieflinkpop, li.brieflinkpop, div.brieflinkpop
	{mso-style-name:brieflinkpop;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.star, li.star, div.star
	{mso-style-name:star;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbisetswitch, li.jig-ncbisetswitch, div.jig-ncbisetswitch
	{mso-style-name:jig-ncbisetswitch;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-button, li.ui-ncbisetswitch-button, div.ui-ncbisetswitch-button
	{mso-style-name:ui-ncbisetswitch-button;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-options, li.ui-ncbisetswitch-options, div.ui-ncbisetswitch-options
	{mso-style-name:ui-ncbisetswitch-options;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.boxed-text-box, li.boxed-text-box, div.boxed-text-box
	{mso-style-name:boxed-text-box;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-from, li.cell-from, div.cell-from
	{mso-style-name:cell-from;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-citation, li.cell-citation, div.cell-citation
	{mso-style-name:cell-citation;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup, li.figpopup, div.figpopup
	{mso-style-name:figpopup;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.button, li.button, div.button
	{mso-style-name:button;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.retraction, li.retraction, div.retraction
	{mso-style-name:retraction;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverarrow, li.mathjaxhoverarrow, div.mathjaxhoverarrow
	{mso-style-name:mathjax_hover_arrow;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pbody, li.pbody, div.pbody
	{mso-style-name:pbody;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box, li.page-box, div.page-box
	{mso-style-name:page-box;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box-wide, li.page-box-wide, div.page-box-wide
	{mso-style-name:page-box-wide;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nomaxwidth, li.nomaxwidth, div.nomaxwidth
	{mso-style-name:no_max_width;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.f, li.f, div.f
	{mso-style-name:f;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.l, li.l, div.l
	{mso-style-name:l;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header-icon, li.ui-accordion-header-icon, div.ui-accordion-header-icon
	{mso-style-name:ui-accordion-header-icon;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-optgroup, li.ui-selectmenu-optgroup, div.ui-selectmenu-optgroup
	{mso-style-name:ui-selectmenu-optgroup;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-anchor, li.ui-tabs-anchor, div.ui-tabs-anchor
	{mso-style-name:ui-tabs-anchor;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-submit, li.ui-ncbibutton-submit, div.ui-ncbibutton-submit
	{mso-style-name:ui-ncbibutton-submit;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-cancel, li.ui-ncbibutton-cancel, div.ui-ncbibutton-cancel
	{mso-style-name:ui-ncbibutton-cancel;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ltd-hover, li.ltd-hover, div.ltd-hover
	{mso-style-name:ltd-hover;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.warn, li.warn, div.warn
	{mso-style-name:warn;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notice, li.notice, div.notice
	{mso-style-name:notice;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content, li.content, div.content
	{mso-style-name:content;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.onelinesource, li.onelinesource, div.onelinesource
	{mso-style-name:one_line_source;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tertiary, li.tertiary, div.tertiary
	{mso-style-name:tertiary;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverframe, li.mathjaxhoverframe, div.mathjaxhoverframe
	{mso-style-name:mathjax_hover_frame;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header1, li.ui-accordion-header1, div.ui-accordion-header1
	{mso-style-name:ui-accordion-header1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:1.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons1, li.ui-accordion-icons1, div.ui-accordion-icons1
	{mso-style-name:ui-accordion-icons1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons2, li.ui-accordion-icons2, div.ui-accordion-icons2
	{mso-style-name:ui-accordion-icons2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header-icon1, li.ui-accordion-header-icon1, div.ui-accordion-header-icon1
	{mso-style-name:ui-accordion-header-icon1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-content1, li.ui-accordion-content1, div.ui-accordion-content1
	{mso-style-name:ui-accordion-content1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text1, li.ui-button-text1, div.ui-button-text1
	{mso-style-name:ui-button-text1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text2, li.ui-button-text2, div.ui-button-text2
	{mso-style-name:ui-button-text2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text3, li.ui-button-text3, div.ui-button-text3
	{mso-style-name:ui-button-text3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon2, li.ui-icon2, div.ui-icon2
	{mso-style-name:ui-icon2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-6.0pt;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button1, li.ui-button1, div.ui-button1
	{mso-style-name:ui-button1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:-.05in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header1, li.ui-datepicker-header1, div.ui-datepicker-header1
	{mso-style-name:ui-datepicker-header1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-next1, li.ui-datepicker-next1, div.ui-datepicker-next1
	{mso-style-name:ui-datepicker-next1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-prev1, li.ui-datepicker-prev1, div.ui-datepicker-prev1
	{mso-style-name:ui-datepicker-prev1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-title1, li.ui-datepicker-title1, div.ui-datepicker-title1
	{mso-style-name:ui-datepicker-title1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:27.6pt;
	margin-bottom:0in;
	margin-left:27.6pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.6pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane1, li.ui-datepicker-buttonpane1, div.ui-datepicker-buttonpane1
	{mso-style-name:ui-datepicker-buttonpane1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:8.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group1, li.ui-datepicker-group1, div.ui-datepicker-group1
	{mso-style-name:ui-datepicker-group1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group2, li.ui-datepicker-group2, div.ui-datepicker-group2
	{mso-style-name:ui-datepicker-group2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group3, li.ui-datepicker-group3, div.ui-datepicker-group3
	{mso-style-name:ui-datepicker-group3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header2, li.ui-datepicker-header2, div.ui-datepicker-header2
	{mso-style-name:ui-datepicker-header2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header3, li.ui-datepicker-header3, div.ui-datepicker-header3
	{mso-style-name:ui-datepicker-header3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane2, li.ui-datepicker-buttonpane2, div.ui-datepicker-buttonpane2
	{mso-style-name:ui-datepicker-buttonpane2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane3, li.ui-datepicker-buttonpane3, div.ui-datepicker-buttonpane3
	{mso-style-name:ui-datepicker-buttonpane3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header4, li.ui-datepicker-header4, div.ui-datepicker-header4
	{mso-style-name:ui-datepicker-header4;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header5, li.ui-datepicker-header5, div.ui-datepicker-header5
	{mso-style-name:ui-datepicker-header5;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-title1, li.ui-dialog-title1, div.ui-dialog-title1
	{mso-style-name:ui-dialog-title1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:1.2pt;
	margin-right:12.0pt;
	margin-bottom:2.4pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-buttonpane1, li.ui-dialog-buttonpane1, div.ui-dialog-buttonpane1
	{mso-style-name:ui-dialog-buttonpane1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:whitesmoke;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-item1, li.ui-menu-item1, div.ui-menu-item1
	{mso-style-name:ui-menu-item1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-divider1, li.ui-menu-divider1, div.ui-menu-divider1
	{mso-style-name:ui-menu-divider1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:3.75pt;
	margin-right:0in;
	margin-bottom:3.75pt;
	margin-left:0in;
	line-height:0%;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-active1, li.ui-state-active1, div.ui-state-active1
	{mso-style-name:ui-state-active1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-focus1, li.ui-state-focus1, div.ui-state-focus1
	{mso-style-name:ui-state-focus1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-menu-item2, li.ui-menu-item2, div.ui-menu-item2
	{mso-style-name:ui-menu-item2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon3, li.ui-icon3, div.ui-icon3
	{mso-style-name:ui-icon3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value1, li.ui-progressbar-value1, div.ui-progressbar-value1
	{mso-style-name:ui-progressbar-value1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-overlay1, li.ui-progressbar-overlay1, div.ui-progressbar-overlay1
	{mso-style-name:ui-progressbar-overlay1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value2, li.ui-progressbar-value2, div.ui-progressbar-value2
	{mso-style-name:ui-progressbar-value2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-handle1, li.ui-resizable-handle1, div.ui-resizable-handle1
	{mso-style-name:ui-resizable-handle1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-resizable-handle2, li.ui-resizable-handle2, div.ui-resizable-handle2
	{mso-style-name:ui-resizable-handle2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-menu1, li.ui-menu1, div.ui-menu1
	{mso-style-name:ui-menu1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-optgroup1, li.ui-selectmenu-optgroup1, div.ui-selectmenu-optgroup1
	{mso-style-name:ui-selectmenu-optgroup1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-slider-handle1, li.ui-slider-handle1, div.ui-slider-handle1
	{mso-style-name:ui-slider-handle1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range1, li.ui-slider-range1, div.ui-slider-range1
	{mso-style-name:ui-slider-range1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:8.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle2, li.ui-slider-handle2, div.ui-slider-handle2
	{mso-style-name:ui-slider-handle2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-.1in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle3, li.ui-slider-handle3, div.ui-slider-handle3
	{mso-style-name:ui-slider-handle3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range2, li.ui-slider-range2, div.ui-slider-range2
	{mso-style-name:ui-slider-range2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon5, li.ui-icon5, div.ui-icon5
	{mso-style-name:ui-icon5;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-anchor1, li.ui-tabs-anchor1, div.ui-tabs-anchor1
	{mso-style-name:ui-tabs-anchor1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tooltip1, li.ui-tooltip1, div.ui-tooltip1
	{mso-style-name:ui-tooltip1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget1, li.ui-widget1, div.ui-widget1
	{mso-style-name:ui-widget1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-default1, li.ui-state-default1, div.ui-state-default1
	{mso-style-name:ui-state-default1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-default2, li.ui-state-default2, div.ui-state-default2
	{mso-style-name:ui-state-default2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-focus2, li.ui-state-focus2, div.ui-state-focus2
	{mso-style-name:ui-state-focus2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover1, li.ui-state-hover1, div.ui-state-hover1
	{mso-style-name:ui-state-hover1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-focus3, li.ui-state-focus3, div.ui-state-focus3
	{mso-style-name:ui-state-focus3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover2, li.ui-state-hover2, div.ui-state-hover2
	{mso-style-name:ui-state-hover2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active2, li.ui-state-active2, div.ui-state-active2
	{mso-style-name:ui-state-active2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active3, li.ui-state-active3, div.ui-state-active3
	{mso-style-name:ui-state-active3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-highlight1, li.ui-state-highlight1, div.ui-state-highlight1
	{mso-style-name:ui-state-highlight1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-highlight2, li.ui-state-highlight2, div.ui-state-highlight2
	{mso-style-name:ui-state-highlight2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-error1, li.ui-state-error1, div.ui-state-error1
	{mso-style-name:ui-state-error1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error2, li.ui-state-error2, div.ui-state-error2
	{mso-style-name:ui-state-error2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text1, li.ui-state-error-text1, div.ui-state-error-text1
	{mso-style-name:ui-state-error-text1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text2, li.ui-state-error-text2, div.ui-state-error-text2
	{mso-style-name:ui-state-error-text2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-priority-primary1, li.ui-priority-primary1, div.ui-priority-primary1
	{mso-style-name:ui-priority-primary1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-primary2, li.ui-priority-primary2, div.ui-priority-primary2
	{mso-style-name:ui-priority-primary2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-secondary1, li.ui-priority-secondary1, div.ui-priority-secondary1
	{mso-style-name:ui-priority-secondary1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-priority-secondary2, li.ui-priority-secondary2, div.ui-priority-secondary2
	{mso-style-name:ui-priority-secondary2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled1, li.ui-state-disabled1, div.ui-state-disabled1
	{mso-style-name:ui-state-disabled1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled2, li.ui-state-disabled2, div.ui-state-disabled2
	{mso-style-name:ui-state-disabled2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon6, li.ui-icon6, div.ui-icon6
	{mso-style-name:ui-icon6;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon7, li.ui-icon7, div.ui-icon7
	{mso-style-name:ui-icon7;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon8, li.ui-icon8, div.ui-icon8
	{mso-style-name:ui-icon8;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon9, li.ui-icon9, div.ui-icon9
	{mso-style-name:ui-icon9;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon10, li.ui-icon10, div.ui-icon10
	{mso-style-name:ui-icon10;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon11, li.ui-icon11, div.ui-icon11
	{mso-style-name:ui-icon11;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon12, li.ui-icon12, div.ui-icon12
	{mso-style-name:ui-icon12;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon13, li.ui-icon13, div.ui-icon13
	{mso-style-name:ui-icon13;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon14, li.ui-icon14, div.ui-icon14
	{mso-style-name:ui-icon14;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-nav1, li.ui-tabs-nav1, div.ui-tabs-nav1
	{mso-style-name:ui-tabs-nav1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tertiary1, li.tertiary1, div.tertiary1
	{mso-style-name:tertiary1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#666666;}
p.tertiary2, li.tertiary2, div.tertiary2
	{mso-style-name:tertiary2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#985735;}
p.ui-tabs-panel1, li.ui-tabs-panel1, div.ui-tabs-panel1
	{mso-style-name:ui-tabs-panel1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-hide1, li.ui-tabs-hide1, div.ui-tabs-hide1
	{mso-style-name:ui-tabs-hide1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-dialog-titlebar1, li.ui-dialog-titlebar1, div.ui-dialog-titlebar1
	{mso-style-name:ui-dialog-titlebar1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.ui-dialog-titlebar-close1, li.ui-dialog-titlebar-close1, div.ui-dialog-titlebar-close1
	{mso-style-name:ui-dialog-titlebar-close1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-content1, li.ui-dialog-content1, div.ui-dialog-content1
	{mso-style-name:ui-dialog-content1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-se1, li.ui-resizable-se1, div.ui-resizable-se1
	{mso-style-name:ui-resizable-se1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon15, li.ui-icon15, div.ui-icon15
	{mso-style-name:ui-icon15;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-hover3, li.ui-state-hover3, div.ui-state-hover3
	{mso-style-name:ui-state-hover3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-ncbibutton-submit1, li.ui-ncbibutton-submit1, div.ui-ncbibutton-submit1
	{mso-style-name:ui-ncbibutton-submit1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:6.55pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-cancel1, li.ui-ncbibutton-cancel1, div.ui-ncbibutton-cancel1
	{mso-style-name:ui-ncbibutton-cancel1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:22.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#2F4A8B;}
p.ui-button-text4, li.ui-button-text4, div.ui-button-text4
	{mso-style-name:ui-button-text4;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref-right1, li.ui-ncbiautocomplete-link-pref-right1, div.ui-ncbiautocomplete-link-pref-right1
	{mso-style-name:ui-ncbiautocomplete-link-pref-right1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text5, li.ui-button-text5, div.ui-button-text5
	{mso-style-name:ui-button-text5;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text6, li.ui-button-text6, div.ui-button-text6
	{mso-style-name:ui-button-text6;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text7, li.ui-button-text7, div.ui-button-text7
	{mso-style-name:ui-button-text7;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:595.95pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text8, li.ui-button-text8, div.ui-button-text8
	{mso-style-name:ui-button-text8;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:595.95pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text9, li.ui-button-text9, div.ui-button-text9
	{mso-style-name:ui-button-text9;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text10, li.ui-button-text10, div.ui-button-text10
	{mso-style-name:ui-button-text10;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon16, li.ui-icon16, div.ui-icon16
	{mso-style-name:ui-icon16;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon17, li.ui-icon17, div.ui-icon17
	{mso-style-name:ui-icon17;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon18, li.ui-icon18, div.ui-icon18
	{mso-style-name:ui-icon18;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon19, li.ui-icon19, div.ui-icon19
	{mso-style-name:ui-icon19;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon20, li.ui-icon20, div.ui-icon20
	{mso-style-name:ui-icon20;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon21, li.ui-icon21, div.ui-icon21
	{mso-style-name:ui-icon21;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary1, li.ui-button-icon-primary1, div.ui-button-icon-primary1
	{mso-style-name:ui-button-icon-primary1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary2, li.ui-button-icon-primary2, div.ui-button-icon-primary2
	{mso-style-name:ui-button-icon-primary2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary3, li.ui-button-icon-primary3, div.ui-button-icon-primary3
	{mso-style-name:ui-button-icon-primary3;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary1, li.ui-button-icon-secondary1, div.ui-button-icon-secondary1
	{mso-style-name:ui-button-icon-secondary1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary2, li.ui-button-icon-secondary2, div.ui-button-icon-secondary2
	{mso-style-name:ui-button-icon-secondary2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-pagecontrol1, li.ui-ncbigrid-paged-pagecontrol1, div.ui-ncbigrid-paged-pagecontrol1
	{mso-style-name:ui-ncbigrid-paged-pagecontrol1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.prev1, li.prev1, div.prev1
	{mso-style-name:prev1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:.1in;
	mso-margin-bottom-alt:auto;
	margin-left:2.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.next1, li.next1, div.next1
	{mso-style-name:next1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:2.4pt;
	mso-margin-bottom-alt:auto;
	margin-left:.1in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-row-count1, li.ui-ncbigrid-select-row-count1, div.ui-ncbigrid-select-row-count1
	{mso-style-name:ui-ncbigrid-select-row-count1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-ncbigrid-outer-div1, li.ui-ncbigrid-outer-div1, div.ui-ncbigrid-outer-div1
	{mso-style-name:ui-ncbigrid-outer-div1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbimenu-item-leaf1, li.ui-ncbimenu-item-leaf1, div.ui-ncbimenu-item-leaf1
	{mso-style-name:ui-ncbimenu-item-leaf1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:9.0pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.brieflinkpop1, li.brieflinkpop1, div.brieflinkpop1
	{mso-style-name:brieflinkpop1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.star1, li.star1, div.star1
	{mso-style-name:star1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:7.4pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbisetswitch1, li.jig-ncbisetswitch1, div.jig-ncbisetswitch1
	{mso-style-name:jig-ncbisetswitch1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:14.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#333333;}
p.ui-ncbisetswitch-button1, li.ui-ncbisetswitch-button1, div.ui-ncbisetswitch-button1
	{mso-style-name:ui-ncbisetswitch-button1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon24, li.ui-icon24, div.ui-icon24
	{mso-style-name:ui-icon24;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:5.55pt;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ltd-hover1, li.ltd-hover1, div.ltd-hover1
	{mso-style-name:ltd-hover1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E8E8E8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon25, li.ui-icon25, div.ui-icon25
	{mso-style-name:ui-icon25;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-options1, li.ui-ncbisetswitch-options1, div.ui-ncbisetswitch-options1
	{mso-style-name:ui-ncbisetswitch-options1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pbody1, li.pbody1, div.pbody1
	{mso-style-name:pbody1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:16.6pt;
	margin-bottom:0in;
	margin-left:16.6pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box1, li.page-box1, div.page-box1
	{mso-style-name:page-box1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box-wide1, li.page-box-wide1, div.page-box-wide1
	{mso-style-name:page-box-wide1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nomaxwidth1, li.nomaxwidth1, div.nomaxwidth1
	{mso-style-name:no_max_width1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content1, li.content1, div.content1
	{mso-style-name:content1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:16.6pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.boxed-text-box1, li.boxed-text-box1, div.boxed-text-box1
	{mso-style-name:boxed-text-box1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.f1, li.f1, div.f1
	{mso-style-name:f1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.l1, li.l1, div.l1
	{mso-style-name:l1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-from1, li.cell-from1, div.cell-from1
	{mso-style-name:cell-from1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.cell-citation1, li.cell-citation1, div.cell-citation1
	{mso-style-name:cell-citation1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup1, li.figpopup1, div.figpopup1
	{mso-style-name:figpopup1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.button1, li.button1, div.button1
	{mso-style-name:button1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#336699;}
p.retraction1, li.retraction1, div.retraction1
	{mso-style-name:retraction1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:red;
	font-size:12.0pt;
	font-family:"Helvetica","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.warn1, li.warn1, div.warn1
	{mso-style-name:warn1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notice1, li.notice1, div.notice1
	{mso-style-name:notice1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:16.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arrowtab1, li.arrowtab1, div.arrowtab1
	{mso-style-name:arrowtab1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.thistab1, li.thistab1, div.thistab1
	{mso-style-name:thistab1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:9.5pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.onelinesource1, li.onelinesource1, div.onelinesource1
	{mso-style-name:one_line_source1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E0E0E0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverarrow1, li.mathjaxhoverarrow1, div.mathjaxhoverarrow1
	{mso-style-name:mathjax_hover_arrow1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:7.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.mathjaxmenuarrow1, li.mathjaxmenuarrow1, div.mathjaxmenuarrow1
	{mso-style-name:mathjax_menuarrow1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","sans-serif";
	color:white;}
p.p, li.p, div.p
	{mso-style-name:p;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.msochpdefault, li.msochpdefault, div.msochpdefault
	{mso-style-name:msochpdefault;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
p.msopapdefault, li.msopapdefault, div.msopapdefault
	{mso-style-name:msopapdefault;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
span.other-issues
	{mso-style-name:other-issues;
	mso-style-unhide:no;}
span.underline
	{mso-style-name:underline;
	mso-style-unhide:no;}
span.double-underline
	{mso-style-name:double-underline;
	mso-style-unhide:no;}
span.bold-double-underline
	{mso-style-name:bold-double-underline;
	mso-style-unhide:no;}
span.ui-icon1
	{mso-style-name:ui-icon1;
	mso-style-unhide:no;}
span.ui-selectmenu-text
	{mso-style-name:ui-selectmenu-text;
	mso-style-unhide:no;}
span.pagelink
	{mso-style-name:page_link;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big
	{mso-style-name:ui-icon-plus-minus-big;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open
	{mso-style-name:ui-icon-plus-minus-big-open;
	mso-style-unhide:no;}
span.collapsabletbodyicon
	{mso-style-name:collapsabletbodyicon;
	mso-style-unhide:no;}
span.ui-icon4
	{mso-style-name:ui-icon4;
	mso-style-unhide:no;}
span.ui-selectmenu-text1
	{mso-style-name:ui-selectmenu-text1;
	mso-style-unhide:no;}
span.pagelink1
	{mso-style-name:page_link1;
	mso-style-unhide:no;
	color:#CCCCCC;}
span.collapsabletbodyicon1
	{mso-style-name:collapsabletbodyicon1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big1
	{mso-style-name:ui-icon-plus-minus-big1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open1
	{mso-style-name:ui-icon-plus-minus-big-open1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big2
	{mso-style-name:ui-icon-plus-minus-big2;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open2
	{mso-style-name:ui-icon-plus-minus-big-open2;
	mso-style-unhide:no;}
span.ui-icon22
	{mso-style-name:ui-icon22;
	mso-style-unhide:no;}
span.ui-icon23
	{mso-style-name:ui-icon23;
	mso-style-unhide:no;}
span.cit
	{mso-style-name:cit;
	mso-style-unhide:no;}
span.fm-vol-iss-date
	{mso-style-name:fm-vol-iss-date;
	mso-style-unhide:no;}
span.doi1
	{mso-style-name:doi1;
	mso-style-unhide:no;}
span.fm-citation-ids-label
	{mso-style-name:fm-citation-ids-label;
	mso-style-unhide:no;}
span.contrib-email
	{mso-style-name:contrib-email;
	mso-style-unhide:no;}
span.figpopup-sensitive-area1
	{mso-style-name:figpopup-sensitive-area1;
	mso-style-unhide:no;
	mso-text-animation:none;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;}
span.tag-json
	{mso-style-name:tag-json;
	mso-style-unhide:no;}
span.citation
	{mso-style-name:citation;
	mso-style-unhide:no;}
span.ref-journal
	{mso-style-name:ref-journal;
	mso-style-unhide:no;}
span.ref-vol
	{mso-style-name:ref-vol;
	mso-style-unhide:no;}
span.nowrap
	{mso-style-name:nowrap;
	mso-style-unhide:no;}
span.acknowledgment-journal-title
	{mso-style-name:acknowledgment-journal-title;
	mso-style-unhide:no;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:719399365;
	mso-list-template-ids:1039951798;}
@list l1
	{mso-list-id:1322387783;
	mso-list-template-ids:365198824;}
@list l1:level1
	{mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level2
	{mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level3
	{mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level4
	{mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level5
	{mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level6
	{mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level7
	{mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level8
	{mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l1:level9
	{mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2
	{mso-list-id:1331719657;
	mso-list-template-ids:-2057146220;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3
	{mso-list-id:1643608880;
	mso-list-template-ids:1907500896;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link=blue vlink=purple style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Breast Cancer Res. 2006; 8(2): R21. </span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Published online 2006 Apr 12. <span class=SpellE><span
class=GramE>doi</span></span>:&nbsp; <a
href="http://dx.doi.org/10.1186%2Fbcr1395" target="pmc_ext">10.1186/bcr1395</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>PMCID: PMC1557711</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:24.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma <i>in
situ </i>of the breast in a human xenograft model and on breast and ovarian
cancer cell growth <i>in vitro </i>and <i>in vivo</i></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=W%26%23x000e4%3Brnberg%20F%5Bauth%5D">Fredrik
<span class=SpellE>Wrnberg</span></a>,</span><sup><span style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-no-proof:yes'><img border=0 width=7
height=9 id="_x0000_i1032" src="PMC1557711%20Table%201_files/image001.gif"
alt="corresponding author"></span></sup><sup><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>1,2</span></sup><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> <a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=White%20D%5Bauth%5D">Daniel
White</a>,<sup>1</sup> <a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Anderson%20E%5Bauth%5D">Elizabeth
Anderson</a>,<sup>1</sup> <a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Knox%20F%5Bauth%5D">Fiona Knox</a>,<sup>3</sup>
<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clarke%20RB%5Bauth%5D">Robert
B Clarke</a>,<sup>1</sup> <a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Morris%20J%5Bauth%5D">Julie
Morris</a>,<sup>4</sup> and <a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Bundred%20NJ%5Bauth%5D">Nigel J
Bundred</a><sup>2</sup></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>1</span></sup><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>Breast Biology Group, Christie Hospital NHS
Trust, Manchester, UK</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>2</span></sup><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>Department of Pathology, South Manchester
University Hospital, Manchester, UK</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>3</span></sup><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>Department of Surgery, South Manchester
University Hospital, Manchester, UK</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>4</span></sup><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>Department of Medical Statistics, South
Manchester University Hospital, Manchester, UK</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-no-proof:yes'><img border=0 width=7 height=9
id="_x0000_i1031" src="PMC1557711%20Table%201_files/image001.gif"
alt="corresponding author"></span></sup><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";display:none;mso-hide:all;mso-ansi-language:
EN'>Corresponding author.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>Fredrik Wrnberg: <a
href="mailto:dev@null">es.aksimedaka@grebnraw.kirderf</a>; Daniel White: <a
href="mailto:dev@null">ku.ca.retsehcnam@etihW.J.leinaD</a>; Elizabeth Anderson:
<a href="mailto:dev@null">moc.acenezartsa@nosrednA.htebazilE</a>; Fiona Knox: <a
href="mailto:dev@null">ku.shn.tsewn.thums@xonK.anoiF</a>; Robert B Clarke: <a
href="mailto:dev@null">ku.ca.retsehcnam@ekralc.trebor</a>; Julie Morris: <a
href="mailto:dev@null">ku.ca.retsehcnam@sirrom.eiluj</a>; Nigel J Bundred: <a
href="mailto:dev@null">ku.ca.retsehcnam@derdnuB.J.legiN</a> </span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic">Author
information &#9658;</a> <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic">Article
notes &#9658;</a> <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic">Copyright
and License information &#9658;</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>Received 2006 Jan 18; Revisions
requested 2006 Feb 14; Revised 2006 Mar 4; Accepted 2006 Mar 11.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a> 
2006 Wrnberg et al.; licensee BioMed Central Ltd.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";display:none;mso-hide:all;
mso-ansi-language:EN'>This is an open access article distributed under the
terms of the Creative Commons Attribution License (<a
href="http://creativecommons.org/licenses/by/2.0" target="pmc_ext">http://creativecommons.org/licenses/by/2.0</a>),
which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>This article has been <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/citedby/">cited by</a>
other articles in PMC.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Abstract</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Introduction</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The <span
class=SpellE>ras</span> pathway is essential for cell growth and proliferation.
<span style='background:yellow;mso-highlight:yellow'>The effects of R115777, a
farnesyl transferase inhibitor, were investigated in cancer cell lines
expressing varying levels of growth factor receptors and with differing <span
class=SpellE>ras</span> status</span>. Effects on <span class=SpellE>tumour</span>
xenografts and human ductal carcinoma <i>in situ </i>(DCIS) of the breast in a
xenograft mouse model were also tested.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Method</span></b></p>

<p class=MsoNormal style='line-height:normal'><i><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>In vitro</span></i><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>, the concentrations required to reduce cell numbers by
50% (50% inhibitory concentration) were established (MDA-MB231, MCF-7,
MCF-7/HER2-18, BT-474, SK-BR3 and SKOV3). Human DCIS was implanted in nude mice
or, in separate experiments, cultured cells were injected (MDA-MB231,
MCF-7/HER2-18, SKOV3) and allowed to form <span class=SpellE>tumours</span>.
Proliferation and apoptosis were determined by immunohistochemistry in
xenografts and cell <span class=SpellE>tumours</span>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Results</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>The 50% inhibitory concentrations varied a
hundred-fold, from 39 <span class=SpellE>nmol</span>/l ( 26 <span
class=SpellE>nmol</span>/l) for SKBR3 to 5.9 <span class=SpellE>&#956;mol</span>/<span
class=GramE>l(</span> 0.8 <span class=SpellE>&#956;mol</span>/l) for
MDA-MB231.</span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> <span style='background:yellow;mso-highlight:yellow'>In
MCF-7/HER2-18 and SKOV3 cells the levels of <span class=SpellE>tumour</span>
growth inhibition were approximately 85% and 40%, respectively.</span> <span
style='background:yellow;mso-highlight:yellow'>There was a significant decrease
in the cell turnover index (CTI; proliferation/apoptosis).</span> <span
style='background:yellow;mso-highlight:yellow'>In MDA-MB 231 with activated k-<span
class=SpellE>ras</span> no inhibition was observed.</span> In treated DCIS
xenografts proliferation decreased and apoptosis increased. The CTI ratio
between the start and 1 and 2 weeks of treatment were 1.99 and 1.50,
respectively, for controls and 0.85 (<i>P </i>= 0.005) and 0.75 (<i>P </i>=
0.08) for treated xenografts.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Conclusion</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>Treatment with the farnesyl transferase inhibitor
reduced cell growth <i>in vitro </i>and cell <span class=SpellE>tumour</span>
growth <i>in vivo</i>.</span><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'> In DCIS treatment resulted in
a reduced CTI. R115777 is a promising treatment for breast cancer but the
relation between effect and growth factor receptor and <span class=SpellE>ras</span>
status has to be established.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Introduction</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>RAS pathway
activity is critical for <span class=SpellE>tumour</span> growth [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B1">1</a>].
In breast cancers, activity of the <span class=SpellE>ras</span> <span
class=SpellE>signalling</span> pathway appears to be increased chiefly via
activation of wild-type <span class=SpellE>ras</span> proteins by upstream
growth factor receptors such as the epidermal growth factor receptor and
c-erbB-2 (HER2) [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B2">2</a>,<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B3">3</a>].
Expression of these receptors is increased in 3040% of all breast cancers [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B4">4</a>];
furthermore, over-expression is indicative of a more aggressive phenotype [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B5">5</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B6">6</a>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Point
mutations in <span class=SpellE>ras</span> genes result in over-activated <span
class=SpellE>ras</span> proteins. The incidence of <span class=SpellE>ras</span>
mutations in human <span class=SpellE>tumours</span> overall is about 30%, whereas
the incidence of activating <span class=SpellE>ras</span> mutations in breast
cancers is low, at only a few percent [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B7">7</a>-<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B9">9</a>].
The <span class=SpellE>ras</span> pathway is activated by a variety of <span
class=SpellE>extracellullar</span> factors [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B10">10</a>]
and aberrant function of the <span class=SpellE>ras</span> signal transduction
pathway is thought to be common in breast cancer [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B2">2</a>].
Preclinical data have suggested that <span class=SpellE>ras</span> inhibition
has an inhibitory effect on growth in cell lines that express both mutated and
wild-type <span class=SpellE>ras</span> [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B11">11</a>-<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B13">13</a>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The <span
class=SpellE>ras</span> proteins play an important role in signal transduction
and cellular transformation [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B14">14</a>].
To function in signal transduction and activation of downstream pathways <span
class=SpellE>ras</span> must attach to the plasma membrane where it can
interact with membrane receptors and downstream effectors such as RAF and
phosphatidylinositol 3-kinase (PI3K). Activation of the RAF-MAPK
(mitogen-activated protein kinase) pathway stimulates proliferation in the
cell, and activation of the PI3K-PKB (protein kinase B)/<span class=SpellE>Akt</span>
pathway is related to increased cell survival [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B15">15</a>].
<span class=SpellE>Ras</span> is synthesized as a pro-peptide (pro-<span
class=SpellE>ras</span>). One way to target <span class=SpellE>ras</span>
activity is to inhibit the enzyme farnesyl transferase, which catalyzes a major
step in the modification of pro-<span class=SpellE>ras</span>. <span
class=SpellE>Farnesylation</span> makes the <span class=SpellE>ras</span>
protein more hydrophobic, and therefore it becomes possible for the protein to
attach to the plasma membrane [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B10">10</a>].
Several different farnesyl transferase inhibitors (FTIs) have been developed. <span
style='background:lime;mso-highlight:lime'>The drug investigated in this study
(R115777) is an imidazole-based FTI that acts as a competitive inhibitor of the
carboxyl-terminal <span class=SpellE>tetrapeptide</span> CAAX of <span
class=SpellE>ras</span> [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B16">16</a>-<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B19">19</a>].</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>In the
present study we tested the effects of the FTI R115777 on growth of breast and
ovarian cancer cell lines expressing varying levels of HER2 and epidermal
growth factor receptor and with differing <span class=SpellE>ras</span> status,
and on ductal carcinoma <i>in situ </i>(DCIS) of the breast in a human
xenograft model. Widespread DCIS was previously used for implantation in
experiments similar to this study [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B20">20</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B21">21</a>].
The take rate of DCIS xenografts has been shown to be high; furthermore, DCIS
express HER2 in 70% of high-grade DCIS lesions [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B22">22</a>,<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B23">23</a>],
which makes DCIS suitable for studies targeting the <span class=SpellE>ras</span>
pathway.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>In this study we have shown that treatment with
the FTI R115777 reduced cell growth <i>in vitro </i>and cell <span
class=SpellE>tumour</span> growth <i>in vivo</i>.</span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> In human DCIS xenografts treatment resulted in a reduced cell turnover
index (CTI).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Materials and methods</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Patients</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Participants
in this study were women who attended the Nightingale Breast Screening
Assessment Centre or the Symptomatic Breast Clinic at the University Hospital
of South Manchester, UK during the period from April 2002 to April 2003. Women
were included in the study if they had mammograms showing widespread <span
class=SpellE>microcalcifications</span> indicative of DCIS, with or without an
invasive component, and histopathological confirmation of the diagnosis by core
biopsy before surgery (<i>n </i>= 14). Written consent was obtained, and only
those women undergoing mastectomy were included. A consultant breast
pathologist subsequently reviewed all tissue samples. Approval to remove tissue
from pathological samples in this study was granted by the South Manchester
Research Ethics Committee.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Animals</span></b></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Athymic</span></span><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'> female nude mice (BALB/c
nu/nu, aged 68 weeks) were purchased and allowed to acclimatize for 12 weeks
before experiments were started. The mice were housed under conventional
conditions with a 12-hour cycle of light and dark in filter top cages (<i>n </i>=
56/cage) and given free access to normal feed, water and bedding during the
experiments. All care of the animals and surgical procedures were performed in
accordance with Home Office Regulations and the UK Scientific Procedures Act
(1986).</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Treatment of ductal carcinoma <i>in situ </i>tissue samples and xenografts</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>A 12 cm<sup>3
</sup>specimen of breast tissue from the area with <span class=SpellE>microcalcifications</span>
was taken at the time of surgery and handled as described previously [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B20">20</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B21">21</a>].
The specimen was dissected into 2  2  1 mm pieces and a random collection of
510 pieces was withdrawn as day 0 samples and processed for histology. The
tissue was collected well away from any areas showing signs of invasive cancer
on the mammogram, and in our day 0 xenografts we found no signs of invasive
cancer. The remaining xenografts were implanted into 530 mice, depending on
tissue volume. Each mouse received tissue from one patient only and
implantation was completed within 90 min of removal of the tissue from the
patient. Eight xenografts (in pairs) were implanted subcutaneously in four
sites symmetrically in the flanks. After 2 weeks one pair of xenografts was
removed and treatment was started (day 14). Another pair of xenografts was
removed after 7 days of treatment (day 21), and the remaining xenografts were
removed after 14 days of treatment (day 28) at the end of the experiment. After
retrieval, the xenografts were immediately fixed in buffered formalin for 24
hours at 4C and then stored in 70% ethanol before paraffin embedding.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Treatment</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>Treatment with R115777 (50 mg/kg or 100 mg/kg;
Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ, USA)
or control vehicle (20% &#946;-<span class=SpellE>cyclodextrin</span>) was
given as a gavage twice daily from Monday to Friday and once daily during
weekends.</span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> Treatment was given over 14 days in the experiments with
human DCIS. In the experiments with implanted cell <span class=SpellE>tumours</span>
the duration of treatment varied between 8 and 29 days in different
experiments, depending on how fast the <span class=SpellE>tumours</span> grew. <span
style='background:yellow;mso-highlight:yellow'>We chose the doses 50 mg/kg and
100 mg/kg, based on data from previous experiments with R115777 [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B12">12</a>].</span></span></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><b><span
lang=EN style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Ras</span></b></span><b><span lang=EN style='font-size:
13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'> activity <i>in
vitro </i>and <i>in vivo</i></span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Cell culture</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>The human breast cancer cell lines MDA-MB231,
MCF-7, MCF-7/HER2-18, BT-474 and SK-BR3 and the human ovarian cancer cell line
SKOV3 were obtained from the American Type Culture Collection (Rockville, MA,
USA) and grown and <span class=SpellE>subcultured</span> according to their
instructions</span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. The breast cancer cell lines were chosen based on their
different expression of growth factor receptors, and the SKOV3 ovarian cell
line was used as a model for <span class=SpellE>oestrogen</span> receptor (ER)
negative and wild-type <span class=SpellE>ras</span> cancer. <span
style='background:yellow;mso-highlight:yellow'>Data concerning growth factor
expression, ER expression and <span class=SpellE>ras</span> protein status were
collected from the literature and are given in Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=true>&#8203;1</a>.</span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=204 height=142 id="_x0000_i1030"
src="PMC1557711%20Table%201_files/image002.png" alt="Table 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=table>Table 1</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN; background:yellow'>Results from cell and cell <span class=SpellE>tumour</span>
experiments</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Assessment of cell growth <i>in vitro</i></span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>The effect of R115777 on cell growth was used to
establish the concentrations required to reduce cell numbers by 50% (50%
inhibitory concentration [IC<sub>50</sub>]).</span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> Cells were plated in 96-well plates in growth medium containing 25% <span
class=SpellE>foetal</span> calf serum (FCS), and after 24 hours the medium was
discarded and replaced with medium containing varying concentrations of R115777
(0, 1 <span class=SpellE>nmol</span>/l, 10 <span class=SpellE>nmol</span>/l,
100 <span class=SpellE>nmol</span>/l, 500 <span class=SpellE>nmol</span>/l, 1 <span
class=SpellE>&#956;mol</span>/l, 5 <span class=SpellE>&#956;mol</span>/l and 10
<span class=SpellE>&#956;mol</span>/l). The plated number of cells and the
concentration of FCS were established for each cell line in separate
experiments to find suboptimal growing conditions for use in the following
experiments with R115777. Treatment was continued until untreated cells reached
confluence. Estimation of cell number was done by means of the <span
class=SpellE>sulphorhodamine</span> B colorimetric assay. Three separate
experiments were conducted for each cell line, in which each concentration of
R115777 was tested in quadruplicate.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Assessment of <span class=SpellE>tumour</span> growth in nude mice</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Cells (24 
10<sup>6</sup>) in a 200 <span class=SpellE>&#956;l</span> solution of growth
medium containing 10% FCS were injected subcutaneously into each flank of each
mouse and allowed to form <span class=SpellE>tumours</span>. In the experiments
involving the <span class=SpellE>oestrogen</span>-dependent MCF-7/HER2-18 cell
line, <span class=SpellE>oestrogen</span> pellets (2 mg) were implanted
subcutaneously at the base of the tail of the mice at the time of cell
injection [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B24">24</a>].
<span style='background:yellow;mso-highlight:yellow'>Treatment with R115777 50
mg/kg or 100 mg/kg or control vehicle (20% &#946;-<span class=SpellE>cyclodextrin</span>)
was begun when measurable <span class=SpellE>tumours</span> were formed in
about 75% of injection sites.</span> Only <span class=SpellE>tumours</span>
that were measurable at the start of treatment were included in the analyses. <span
class=SpellE>Tumours</span> were measured with a <span class=SpellE>calliper</span>
twice weekly and <span class=SpellE>tumour</span> volume was calculated using
the following formula: <span class=SpellE>tumour</span> volume = (width<span
class=GramE>)<sup>2</sup></span><sup> </sup> (length/2). Each experiment was
terminated and all <span class=SpellE>tumours</span> were removed when any of
the mice developed a <span class=SpellE>tumour</span> burden of more than 1 cm<sup>3</sup>.
<span class=SpellE>Tumours</span> were divided and processed for
immunohistochemistry or were stored in liquid nitrogen. The growth inhibitory
effect of R115777 was calculated using the following formula: 1 - ([D - C]/[<span
class=SpellE>B<sub>median</sub></span><sub> </sub>- <span class=SpellE>A<sub>median</sub></span>])
 100%, where D is the final <span class=SpellE>tumour</span> volume after
R115777 treatment, C is the <span class=SpellE>tumour</span> volume before
R115777 treatment, B is the median final <span class=SpellE>tumour</span>
volume among control <span class=SpellE>tumours</span> after treatment, and A
is the median <span class=SpellE>tumour</span> volume among control <span
class=SpellE>tumours</span> before treatment. For each of the cell lines two
separate experiments were conducted and the median growth inhibition among all
R115777-treated <span class=SpellE>tumours</span> was calculated.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Assessment of proliferation index, apoptotic index and cell turnover index</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Sections of
DCIS xenografts and cell <span class=SpellE>tumours</span> were scored for
proliferation after Ki67 <span class=SpellE>immunohistochemical</span> staining
(MIB-1; Coulter-<span class=SpellE>Immunotech</span>, <span class=SpellE>Luton</span>,
UK). At least 300 cells in the xenografts and 1,000 cells in the cell <span
class=SpellE>tumours</span> were counted at a magnification of 40. To assess
apoptosis in the xenografts, we sought morphological evidence of apoptosis
using <span class=SpellE>haematoxylin</span> and eosin stained sections. In the
cell <span class=SpellE>tumours</span> immunohistochemistry (<span
class=SpellE>TdT</span>-mediated <span class=SpellE>dUTP</span>-fluorescence
nick end labelling) was used. At least 1,000 cells were counted at a
magnification of 40. Proliferation and apoptotic indices were both expressed
as a percentage of apoptotic or stained cells. The immunohistochemistry
methodology and apoptotic scoring was described previously [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B21">21</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B25">25</a>-<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B27">27</a>].
A CTI (proliferation index/apoptotic index) [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B28">28</a>]
was calculated for each individual xenograft and cell <span class=SpellE>tumour</span>.
All counting was performed without knowledge of treatment group.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Assessment of farnesyl transferase inhibition <i>in vitro </i>and <i>in
vivo</i></span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Western
blots were performed on MCF-7 and MCF-7/HER2-18 cells treated with different
doses of R115777 and on MCF-7/HER2-18 <span class=SpellE>tumours</span> from
the <i>in vivo </i>experiments. Protein extracts were prepared from cell
pellets or <span class=SpellE>tumours</span> after thawing the cryopreserved
samples and washing them with phosphate-buffered saline. The cells were lysed
in ice-cold <span class=SpellE>radioimmunoprecipitation</span> assay buffer (50
<span class=SpellE>mmol</span>/l <span class=SpellE>Tris-HCl</span> [pH 7.5],
150 <span class=SpellE>mmol</span>/l <span class=SpellE>NaCl</span>, 0.1%
Triton X-100, 0.5% <span class=SpellE>deoxycholate</span>, 0.1 <span
class=SpellE>mmol</span>/l <span class=SpellE>ethyleneglycoltetracetic</span>
acid, and 0.1 <span class=SpellE>mmol</span>/l EDTA) with protease inhibitors
for 5 minutes on ice. The protein concentration of each lysate was quantified
using a colorimetric assay (BCA Protein Assay; Pierce, Rockford, IL, USA) and
50 <span class=SpellE>&#956;g</span> total <span class=GramE>protein</span> was
loaded on an 8% SDS polyacrylamide gel. The Western blots were transferred to <span
class=SpellE>polyvinyledene</span> difluoride membrane and probed with a mouse
monoclonal antibody against HDJ2 (KH2A5.6; <span class=SpellE>NeoMarkers</span>,
Fremont, CA, USA) [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B29">29</a>].
Bound antibody was detected using a horseradish peroxidase conjugated secondary
antibody and visualized by treating the membrane with enhanced <span
class=SpellE>chemiluminescence</span> reagents (<span class=SpellE>Amersham</span>
Pharmacia Biotech Inc., Piscataway, NJ, USA) and exposing it to film. Detection
of an <span class=SpellE>unfarnesylated</span> and a <span class=SpellE>farnesylated</span>
band of the HDJ2 protein represents conclusive evidence of farnesyl transferase
inhibition.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Statistical analysis</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>The IC<sub>50</sub>s are presented as the mean
value of three separate experiments with the corresponding standard errors of
the mean.</span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> <span style='background:yellow;
mso-highlight:yellow'>Tumour growth inhibition is given as a percentage.</span> <span
style='background:yellow;mso-highlight:yellow'>The percentage with
interquartile range is based on the median growth inhibition among treated <span
class=SpellE>tumours</span> relative to the median control <span class=SpellE>tumour</span>
growth.</span> Statistical significance of <span class=SpellE>tumour</span>
growth inhibition was tested by comparing individual <span class=SpellE>tumour</span>
growth in cubic <span class=SpellE>millimetres</span> between treated and
control <span class=SpellE>tumours</span> using the Mann-Whitney <i>U</i> test.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Comparisons
between the R115777 treated and control samples in the DCIS xenograft
experiments were made 'within-patient' using a repeated analysis of variance
model with patient and group (R155777 versus control) as factors. This
statistical model matched the <a
href="http://www.ncbi.nlm.nih.gov/nuccore/R11577"><span style='display:none;
mso-hide:all'>{&quot;type&quot;:&quot;entrez-nucleotide&quot;,&quot;attrs&quot;:{&quot;text&quot;:&quot;R11577&quot;,&quot;term_id&quot;:&quot;764312&quot;,&quot;term_text&quot;:&quot;R11577&quot;}}</span>R11577</a>
and control readings from mice transplanted from the same women. Data were
restricted to those mice with tissue from women with readings available from
both R115777 and control mice. Throughout the analysis, 'mouse' was taken as
the unit of analysis and only data from mice with data from both day 14 and day
21 or day 28 were included, because we looked at change over time in terms of
proliferation, apoptosis and CTIs. Data are presented as the geometric means
with their 95% confidence intervals. The significance level was set at 5% and
all tests were two sided. Statistical analysis was performed using STATA
software (STATA Corporation, College Station, TX, USA).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Results</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Cell growth</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>IC<sub>50 </sub>for R115777 varied a hundred-fold,
from 39 <span class=SpellE>nmol</span>/l and 46 <span class=SpellE>nmol</span>/l
for SK-BR3 and MCF-7 to 2.7 <span class=SpellE>&#956;mol</span>/l and 5.9 <span
class=SpellE>&#956;mol</span>/l for SKOV3 and MDA-MB231 cell lines,
respectively, when grown <i>in vitro </i>(Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=true>&#8203;1</a>).</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> <span style='background:yellow;mso-highlight:yellow'>The
cell line with the mutated k-<span class=SpellE>ras</span>, namely MDA-MB231,
had the highest IC<sub>50</sub>, whereas in the cell lines with wild-type <span
class=SpellE>ras</span> the drug was effective at lower doses.</span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>In mice, growth of MCF-7/HER2-18 <span
class=SpellE>tumours</span> was inhibited by R115777 50 mg/kg (<i>n </i>= 19)
and 100 mg/kg (<i>n </i>= 11) by 80.8% (interquartile range 56.499.0%; <i>P </i>=
0.001) and 95.9% (68.2110.1%; <i>P </i>= 0.02), respectively, compared with
control <span class=SpellE>tumours</span> (<i>n </i>= 22; Figure <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F1/"
target=figure>&#8203;1a</a>
and Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=true>&#8203;1</a>).</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> The proliferation index was lower in the treated <span
class=SpellE>tumours</span>; for R115777 50 mg/kg it was 69.6% (63.474.8%; <i>P
</i>= 0.003) and for R115777 100 mg/kg it was 65.5% (62.070.1%; <i>P </i>&lt;
0.0001) as compared with 77.7% for the control <span class=SpellE>tumours</span>
(74.481.1%; Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=true>&#8203;<span style='text-decoration:none;text-underline:none'>Table2).</span>2</a>).
The apoptotic index was higher in the treated <span class=SpellE>tumours</span>;
for R115777 50 mg/kg it was 1.5% (1.21.6%; <i>P </i>= 0.04) and for R115777
100 mg/kg it was 1.6% (1.41.9%; <i>P </i>= 0.003) as compared with 1.2% in the
control <span class=SpellE>tumours</span> (0.91.5%). The CTIs for <span
class=SpellE>tumours</span> treated with R115777 50 mg/kg and 100 mg/kg were
48.7 (41.657.4; <i>P </i>= 0.0009) and 38.0 (30.143.3; <i>P </i>&lt; 0.0001),
respectively, and these values were statistically significantly reduced as
compared with the CTI of 61.6 in controls (55.579.5; Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=true>&#8203;<span style='text-decoration:none;text-underline:none'>Table2</span>2</a>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F1/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=55 id="_x0000_i1029"
src="PMC1557711%20Table%201_files/image003.gif" alt="Figure 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F1/"
target=figure>Figure 1</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=SpellE><span class=GramE><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Tumour</span></span></span><span
class=GramE><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> growth inhibition.</span></span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> <b>(a) </b><span class=SpellE>Tumour</span> growth inhibition in
MCF-7/HER2-18 <span class=SpellE>tumours</span> grown in <span class=SpellE>athymic</span>
mice treated with R115777 50 mg/kg or 100 mg/kg. Median <span class=SpellE>tumour</span>
volume in treated relative to control animals is given in cubic <span
class=SpellE>millimetres</span>. <b>(b) </b><span class=SpellE>Tumour</span> <span
class=GramE>growth <b>...</b></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=204 height=142 id="_x0000_i1028"
src="PMC1557711%20Table%201_files/image004.png" alt="Table 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=table>Table 2</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Apoptosis and proliferation in cell <span class=SpellE>tumour</span>
experiments</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>Growth of SKOV3 <span class=SpellE>tumours</span>
was inhibited by R115777 50 mg/kg (<i>n </i>= 30) and 100 mg/kg (<i>n </i>= 14)
by 60.1% (32.383.9%; <i>P </i>= 0.04) and 20.4% (-65.7 to +38.3%; <i>P </i>=
0.4), respectively, as compared with that in control <span class=SpellE>tumours</span>
(<i>n </i>= 14; Figure <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F1/"
target=figure>&#8203;1b</a>
and Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=true>&#8203;1</a>).</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> The proliferation index was lower in treated <span
class=SpellE>tumours</span>; for R115777 50 mg/kg it was 34.1% (26.544.4%; <i>P
</i>= 0.009) and for R115777 100 mg/kg it was 40.1% (33.144.0%; <i>P </i>=
0.08) as compared with 46.6% in the control <span class=SpellE>tumours</span>
(37.655.0%). The apoptotic index did not differ between treated <span
class=SpellE>tumours</span>; for R115777 50 mg/kg it was 0.49% (0.40.7%; <i>P </i>=
0.11), for R115777 100 mg/kg it was 0.48% (0.40.8%; <i>P </i>= 0.18) and it
was 0.35% in the control <span class=SpellE>tumours</span> (0.30.5%). The CTIs
for <span class=SpellE>tumours</span> treated with R115777 50 mg/kg and 100
mg/kg were 67.5 (45.696.1; <i>P </i>= 0.004) and 81.0 (38.6110.2; <i>P </i>=
0.05), respectively; these values were statistically significantly reduced as
compared with the CTI of 125.4 in controls (87.1188.9; Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=true>&#8203;<span style='text-decoration:none;text-underline:none'>Table2</span>2</a>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>Growth of k-<span class=SpellE>ras</span> mutated
MDA-MB231 <span class=SpellE>tumours</span> was not inhibited by R115777 50
mg/kg (<i>n </i>= 25) and 100 mg/kg (<i>n </i>= 15).</span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> <span style='background:yellow;mso-highlight:yellow'>Instead, the growth
in the treated <span class=SpellE>tumours</span> was increased by 68.8%
(13.8284.1%; <i>P </i>= 0.08) and 91.2% (2.8328.8%; <i>P </i>= 0.09),
respectively, relative to control <span class=SpellE>tumours</span> (<i>n </i>=
16; Figure <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F1/"
target=figure>&#8203;1c</a>
and Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T1/"
target=true>&#8203;1</a>).</span>
The proliferation index was higher, although not statistically significantly
higher, in the treated <span class=SpellE>tumours</span>; for R115777 50 mg/kg
it was 68.2% (63.371.5%; <i>P </i>= 0.24) and for R115777 100 mg/kg it was
72.4% (66.478.4%; <i>P </i>= 0.06) as compared with 57.9% in the control <span
class=SpellE>tumours</span> (54.171.4%). The apoptotic index was similar in
treated and control <span class=SpellE>tumours</span>; for R115777 50 mg/kg it
was 0.4% (0.30.6%; <i>P </i>= 0.98), for R115777 100 mg/kg it was 0.4%
(0.30.7%; <i>P </i>= 0.75) and for controls it was 0.4% (0.30.6%). The CTIs
for <span class=SpellE>tumours</span> treated with R115777 50 mg/kg and 100
mg/kg were 180.1 (115.9205.4; <i>P </i>= 0.32) and 180.8 (90.5227.7; <i>P </i>=
0.37), respectively, and the CTI for controls was 106.0 (85.8191.0; Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T2/"
target=true>&#8203;<span style='text-decoration:none;text-underline:none'>Table2</span>2</a>).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>In the
xenograft experiments no difference in body weight was seen between R115777 and
controls; neither was there any difference in the number of deaths seen between
treated and control animals.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Ductal carcinoma <i>in situ</i></span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Tissue from
14 women with widespread DCIS was implanted. In four of the cases no DCIS was
found in the day 0 xenografts or in the implanted <span class=GramE>xenografts,</span>
and these women were excluded from further analyses. The median age among the
remaining 10 women with implanted DCIS was 53 years (range 3972 years). Nine
out of the 10 women had foci of invasive cancer in their mastectomy specimen
according to the final histopathological report. Nine lesions were nuclear
grade III and the remaining lesions were nuclear grade II. The grading was done
on the <i>in situ </i>part only in lesions with invasive cancer. Accordingly, the
data presented on proliferation, apoptosis and CTI are from the 10 experiments
with implanted DCIS. Four experiments were conducted with the dose R115777 50
mg/kg and six with 100 mg/kg. Eight out of the 10 cases of DCIS were ER
positive (for instance, &gt;5% stained cells). Seven of the cases were
clinically regarded as positive for HER2 (2+ or 3+) and three were regarded as
negative (0 or 1+).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Fifty-four
out of 80 (67.5%) day 0 xenografts contained ducts with DCIS. The harvested
xenograft pairs contained DCIS in 44.8% (493/1100). Accordingly, the overall
take rate was calculated at 66.4%.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The
proliferation and apoptotic indices and CTI from the DCIS experiments are
presented in Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T3/"
target=true>&#8203;<span style='text-decoration:none;text-underline:none'>Table3.</span>3</a>.
There was decreased proliferation in the xenografts treated with R115777. The
ratios of proliferation indices between day 14 and day 21 were 1.38 for
controls (<i>n </i>= 65) and 0.75 for treated (<i>n </i>= 61) xenografts,
respectively (<i>P </i>= 0.04). The ratios between day 14 and day 28 were 1.22
for controls (<i>n </i>= 75) and 0.78 for treated (<i>n </i>= 66) xenografts,
respectively (<i>P </i>= 0.06).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T3/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=204 height=140 id="_x0000_i1027"
src="PMC1557711%20Table%201_files/image005.png" alt="Table 3"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/table/T3/"
target=table>Table 3</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Results from experiments conducted in human DCIS
xenografts</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Apoptosis
increased in the treated DCIS xenografts. The ratios between day 14 and day 28
were 0.83 for controls (<i>n </i>= 95) and 1.06 for treated (<i>n </i>= 104)
xenografts, respectively (<i>P </i>= 0.005).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Overall, CTI
decreased in treated xenografts. The ratios of CTIs between day 14 and day 21
were 1.99 for controls (<i>n </i>= 44) and 0.85 for treated (<i>n </i>= 49)
xenografts, respectively (<i>P </i>= 0.005). The ratios between day 14 and day
28 were 1.50 for controls (<i>n </i>= 67) and 0.75 for treated (<i>n </i>= 62)
xenografts, respectively (<i>P </i>= 0.08). The results of proliferation and
apoptosis in the experiments with the different doses of R115777 pointed in the
same direction, except for an unchanged apoptotic index after 7 days of
treatment in the lower dose group (data not shown).</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>There was no
statistically significant difference in body weight loss/gain or number of
deaths between treated and control animals in the DCIS xenograft experiments.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Farnesyl transferase inhibition</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>In all MCF-7
and MCF-7/HER2-18 cell samples treated with different doses of R115777 <i>in
vitro</i>, an <span class=SpellE>unfarnesylated</span> <span class=SpellE>ras</span>
band was detected with Western blot technique. This <span class=SpellE>unfarnesylated</span>
<span class=SpellE>ras</span> band was not detected in any of the untreated
cell samples (Figure <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F2/"
target=figure>&#8203;<span style='text-decoration:none;text-underline:none'>(Figure2a).</span>2a</a>).
The cell <span class=SpellE>tumours</span> chosen in this analysis were
MCF-7/HER2-18 <span class=SpellE>tumours</span> showing good response on
R115777 treatment and MCF-7/HER2-18 control <span class=SpellE>tumours</span>
with uninhibited growth. This selection of <span class=SpellE>tumours</span>
was made in an attempt to establish proof of farnesyl <span class=SpellE>tranferase</span>
inhibition <i>in vivo</i>. In four out of five treated MCF-7/HER2-18 <span
class=SpellE>tumours</span> an <span class=SpellE>unfarnesylated</span> <span
class=SpellE>ras</span> band was detected, whereas in six out of six control <span
class=SpellE>tumours</span> no <span class=SpellE>unfarnesylated</span> <span
class=SpellE>ras</span> was detected (Figure <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F2/"
target=figure>&#8203;<span style='text-decoration:none;text-underline:none'>(Figure2b</span>2b</a>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F2/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=16 id="_x0000_i1026"
src="PMC1557711%20Table%201_files/image006.gif" alt="Figure 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/figure/F2/"
target=figure>Figure 2</a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>Farnesyl transferase inhibition
<i>in vitro </i>and <i>in vivo</i>.</span></span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> <b>(a) </b>Detection of an <span class=SpellE>unfarnesylated</span> and a <span
class=SpellE>farnesylated</span> band of the HDJ2 protein by Western blot technique
on cell pellets treated with different doses of R115777 and controls. All
treated cell <span class=GramE>pellets <b>...</b></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Discussion</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>In this
study we demonstrated reduced <span class=SpellE>tumour</span> growth <i>in
vivo </i>and reduced cell growth <i>in vitro </i>in human cancer cell lines
with wild-type <span class=SpellE>ras</span> and varying levels of growth
factor receptors, when treated with the FTI R115777. We have shown that the
effect on growth is related to a reduced CTI in the cancer cell lines <span
class=SpellE>tumours</span> <i>in vivo </i>and that the CTI was statistically
significantly reduced in human DCIS treated by the FTI after 1 week. The effect
on the CTI was due to both an <span class=SpellE>antiproliferative</span> and a
pro-apoptotic effect.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To study the
effect of an FTI, we conducted a series of experiments: first, the <i>in vitro </i>studies
on different human cancer cell lines; second, <i>in vivo </i>studies of <span
class=SpellE>tumour</span> growth inhibition in selected cell lines; and,
finally, studies of human DCIS implanted directly from the operating theatre
into nude mice in a model earlier used in our department. The <span
class=SpellE>ras</span> pathway is activated by a variety of <span
class=SpellE>extracellullar</span> factors, and aberrant function of <span
class=SpellE>ras</span> signal transduction is not only due to <span
class=SpellE>ras</span> mutations. We could not assess activation of the <span
class=SpellE>ras</span> <span class=SpellE>signalling</span> pathway, but chose
to study the downstream effects of the FTI, measured as change in apoptosis and
proliferation. We also tried to relate the effect of the FTI to growth factor
receptor status and <span class=SpellE>ras</span> status. Furthermore, by
showing an <span class=SpellE>unfarnesylated</span> protein in treated cell
pellets and cell line <span class=SpellE>tumours</span>, we demonstrated the
effect on <span class=SpellE>farnesylation</span> by the FTI R115777.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Strikingly,
we found an effect on proliferation and apoptosis that was consistent in the <i>in
vivo </i>studies of cell <span class=SpellE>tumours</span> expressing wild-type
<span class=SpellE>ras</span> (MCF-7/HER2-18 and SKOV3) and in human DCIS. The
results of growth inhibition <i>in vitro </i>were in accordance with the <i>in
vivo </i>results (for instance, the largest effect on <span class=SpellE>tumour</span>
growth <i>in vivo </i>was seen in the cell line with the lowest IC<sub>50 </sub><i>in
vitro</i>). No <span class=SpellE>antiproliferative</span> effect and no
pro-apoptotic effect were seen in the k-<span class=SpellE>ras</span> mutated
MDA-MB231 <span class=SpellE>tumours</span> treated with the FTI, and no <span
class=SpellE>tumour</span> growth inhibition resulting from treatment was observed
in this cell line. The MDA-MB231 cell line also had the highest IC<sub>50</sub>.
Other FTIs have been shown to inhibit both mutated and wild-type <span
class=SpellE>ras</span> [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B30">30</a>,<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B31">31</a>],
but a relative resistance to FTIs in k-<span class=SpellE>ras</span> mutated
cell lines has also been reported [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B32">32</a>,<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B33">33</a>].
Although we were unable to establish the <span class=SpellE>ras</span> status
of the DCIS lesions in our human DCIS xenograft experiments, the majority (70%)
were HER2 positive and would be expected to have activated wild-type <span
class=SpellE>ras</span>. We found no areas of invasive breast cancer in our day
0 xenografts. However, if some mixture of invasive cancer cells had occurred in
the xenografts, then this should have been evenly distributed between controls
and treated animals, therefore causing no bias.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The cell
lines considered in our <i>in vitro </i>experiments were selected to represent
different expressions of growth factor receptor and ERs. We were unable to
detect a clear relationship between any of the factors and the effect of the
FTI. For example, the IC<sub>50</sub>s in the MCF-7 and in the MCF-7/HER2-18
were not significantly different in the <i>in vitro </i>experiments. The
MCF-7/HER2-18 is a MCF-7 cell line with 45-fold over-expression of the HER2
receptor caused by transfection with full-length HER2 cDNA [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B34">34</a>].
However, in an experiment similar to ours, in which cell line <span
class=SpellE>tumour</span> growth inhibition was studied and the same FTI was
used, <span class=SpellE>Kelland</span> and coworkers [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B12">12</a>]
identified inhibition of about 6070% in treated MCF-7 cell line <span
class=SpellE>tumours</span>. This was less than the inhibition of approximately
80% we found on the MCF-7/HER2-18 <span class=SpellE>tumours</span>, using the
same dose of R115777. This might be an indication that HER2 expression plays a
role in the response to farnesyl transferase <i>in vivo</i>. The effect on the
HER2 transfected MCF-7 cell line <span class=SpellE>tumours</span> was also
considerably more pronounced than the effect on the SKOV3 cell <span
class=SpellE>tumours</span>, and this was also reflected in a 10-fold lower IC<sub>50</sub>.
Other studies [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B11">11</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B13">13</a>]
also were unable to show a clear relation between markers such as growth factor
receptors and <span class=SpellE>ras</span> status, and the effect of FTIs. As
in the work by <span class=SpellE>Kelland</span> and colleagues, we found no
dose respond effect with the chosen doses, namely 50 and 100 mg/kg. The
mechanism might be a threshold effect or due to <span class=SpellE>saturable</span>
drug pharmacokinetics [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B12">12</a>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>We did not
study the effect of the FTI in subgroups of DCIS (for example, ER
positive/negative or HER2 positive/negative). We stratified by treatment dose
of R115777, but it was not possible to compare the results between the two
different doses because the number of xenografts was too small after
stratification. However, all results of proliferation and apoptotic change in
the different groups pointed in the same direction, except for an unchanged
apoptotic index after seven days of treatment in the lower dose group.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Clinical
studies of R115777 in phase I trials have shown that a reversible
myelosuppression is the dose-limiting toxicity of the drug [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B35">35</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B36">36</a>].
In a phase II study of continuous and intermittent dosing of <a
href="http://www.ncbi.nlm.nih.gov/nuccore/R15777"><span style='display:none;
mso-hide:all'>{&quot;type&quot;:&quot;entrez-nucleotide&quot;,&quot;attrs&quot;:{&quot;text&quot;:&quot;R15777&quot;,&quot;term_id&quot;:&quot;768061&quot;,&quot;term_text&quot;:&quot;R15777&quot;}}</span>R15777</a>
in women with advanced breast cancer [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B37">37</a>],
partial response or stable disease was demonstrated in about 20% of treated
women. Forty-one of the primary <span class=SpellE>tumours</span> in the study
conducted by Johnston and coworkers [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B37">37</a>]
were analyzed for <span class=SpellE>ras</span> mutations and only one <span
class=SpellE>tumour</span> had an h-<span class=SpellE>ras</span> mutation. No
correlation between response and ER and/or HER2 expression was seen in the
study. No clinical studies involving FTIs in patients with DCIS have been
performed, and knowledge on <span class=SpellE>ras</span> status in DCIS
lesions is sparse. In one study [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B38"><span
class=GramE>38</span></a><span class=GramE>] two out of 25 DCIS lesions
over-expressed wild-type k-<span class=SpellE>ras</span>, and in another study
[<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B39">39</a></span>]
four out of five DCIS patients expressed detectable plasma levels of wild-type <span
class=SpellE>ras</span>, but no <span class=SpellE>ras</span> mutations were
found in these studies.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>We have
shown that the FTI was effective in some <span class=SpellE>tumours</span> and
not in others. In the future, it might be possible to identify those <span
class=SpellE>tumours</span> that will benefit from treatment with a FTI. A
series of new signal transduction inhibitors (STIs) are under development [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B40">40</a>].
By gaining a better understanding of how different interactions in normal or
upregulated or downregulated signal pathways work, we hopefully will be able to
tailor breast cancer treatment to individual patients. Furthermore, data
suggest that combining STIs and endocrine therapy may be more effective than an
STI alone [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B41">41</a>-<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B43">43</a>].
There is a lack of correlation between preclinical results with FTIs and
results from clinical studies. Inhibition of <span class=SpellE>farnesylation</span>
has not been clearly correlated to <span class=SpellE>tumour</span> inhibition
in cancer patients [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B44">44</a>].
There is a need to identify the targets of the FTIs in the preclinical setting
if we are to understand the clinical results and be able to select patients in
future studies. Breast cancer is potentially a suitable <span class=SpellE>tumour</span>
type for study because it is possible to perform experiments similar to ours in
which human <span class=SpellE>tumours</span> can be tested in a xenograft
model.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The exact
mechanism of action FTIs on cancer cells remains unknown. Other <span
class=SpellE>ras</span>-independent mechanisms of action might play a role in
the <span class=SpellE>antitumour</span> effect, including inhibition of
enzymes other than the farnesyl transferases [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B44">44</a><span
class=GramE>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#B45">45</a>].
We have clearly demonstrated inhibition of <span class=SpellE>farnesylation</span>
<i>in vitro </i>in the present study. We also demonstrated an effect on <span
class=SpellE>farnesylation</span> in cell <span class=SpellE>tumours</span>,
with good response to R115777 treatment. However, the effect was not as clear
as in the <i>in vitro </i>setting and varied among the treated <span
class=SpellE>tumours</span>. This indicates that mechanisms other than farnesyl
transferase inhibition are involved in <span class=SpellE>tumour</span> growth
inhibition.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Conclusion</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:yellow;mso-highlight:
yellow;mso-ansi-language:EN'>Treatment with the FTI reduced cell growth <i>in
vitro</i>.</span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> Also, cell <span class=SpellE>tumour</span> growth <i>in
vivo </i>was reduced, and we showed increased apoptosis and decreased proliferation,
resulting in reduced CTI. In human DCIS xenografts treatment also resulted in a
reduced CTI. The FTI R115777 is a promising new treatment for breast cancer.
The type of <span class=SpellE>tumours</span> that respond to farnesyl
transferase inhibition must be established before the treatment can become
clinically useful. We are planning further investigations into the mechanisms
of action of the FTIs and how they affect the different pathways that regulate
cell survival and proliferation.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Abbreviations</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";background:aqua;mso-highlight:
aqua;mso-ansi-language:EN'>CTI = cell turnover index;</span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> <span style='background:aqua;mso-highlight:aqua'>DCIS = ductal carcinoma <i>in
situ</i>;</span> <span style='background:aqua;mso-highlight:aqua'>ER = <span
class=SpellE>oestrogen</span> receptor;</span> <span style='background:aqua;
mso-highlight:aqua'>FCS = <span class=SpellE>foetal</span> calf serum;</span> <span
style='background:aqua;mso-highlight:aqua'>FTI = farnesyl transferase inhibitor;</span>
<span style='background:aqua;mso-highlight:aqua'>IC<sub>50 </sub>= 50%
inhibitory concentration;</span> <span style='background:aqua;mso-highlight:
aqua'>PI3K = phosphatidylinositol 3-kinase;</span> <span style='background:
aqua;mso-highlight:aqua'>STI = signal transduction inhibitor.</span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Competing interests</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The research
was partly sponsored by Johnson and Johnson Pharmaceutical Research and
Development, New Jersey, USA.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Authors' contributions</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>FW
participated in the design of the study, carried out the cell and <span
class=SpellE>tumour</span> experiments, obtained patient consent and collected
human DCIS tissue, performed part of the statistical analysis and drafted the
manuscript. DW participated in the design of the study, carried out the cell
and <span class=SpellE>tumour</span> experiments, and carried out the
immunoassays and Western blots. EA participated in the design and coordination
of the study. FK participated in the design of the study, classified the human
DCIS tissue and helped with the counting of proliferation and apoptosis in <span
class=SpellE>tumour</span> cells. RBC participated in the design and
coordination of the study. JM participated in the design of parts of the study
and performed the statistical analysis. NJB participated in the design and
coordination of the study and helped to draft the manuscript. All authors read
and approved the final manuscript.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic"
title="Go to other sections in this page">Go to:</a></span></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>References</span></b></p>

</div>

<ol style='margin-top:0in' start=1 type=1>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Rowinsky</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> EK, <span class=SpellE>Windle</span>
     JJ, Von Hoff DD. <span class=SpellE>Ras</span> protein
     farnesyltransferase: a strategic target for anticancer therapeutic
     development. J <span class=SpellE>Clin</span> <span class=SpellE>Oncol</span>.
     1999<span class=GramE>;17:3631</span>3652. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10550163" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Clark GJ, Der CJ. Aberrant function of the <span
     class=SpellE>Ras</span> signal transduction pathway in human breast
     cancer. Breast Cancer Res Treat. 1995<span class=GramE>;35:133</span>144.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1007/BF00694753. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7612899"
     target="pmc_ext">PubMed</a>] [<a
     href="http://dx.doi.org/10.1007%2FBF00694753" target="pmc_ext">Cross Ref</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Dankort</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> DL, Muller WJ. Signal transduction in mammary
     tumorigenesis: a transgenic perspective. Oncogene. 2000<span class=GramE>;19:1038</span>1044.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1038/sj.onc.1203272. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10713687" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1038%2Fsj.onc.1203272" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>DeFazio A, <span class=SpellE>Chiew</span> YE, Sini
     RL, Janes PW, Sutherland RL. Expression of c-<span class=SpellE>erbB</span>
     receptors, <span class=SpellE>heregulin</span> and <span class=SpellE>oestrogen</span>
     receptor in human breast cell lines. <span class=SpellE>Int</span> J
     Cancer. 2000<span class=GramE>;87:487</span>498. <span class=SpellE>doi</span>:
     10.1002/1097-0215(20000815)87:4&lt;487::AID-IJC5&gt;3.0.CO;2-J. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10918187" target="pmc_ext">PubMed</a>]
     [<a
     href="http://dx.doi.org/10.1002%2F1097-0215(20000815)87%3A4%3C487%3A%3AAID-IJC5%3E3.0.CO%3B2-J"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Oehler</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> MK, Rehn M, Kristen P, <span class=SpellE>Sutterlin</span>
     M, <span class=SpellE>Caffier</span> H. Correlation of the EGF-receptor
     with cell kinetic and classical prognostic factors in breast cancer.
     Anticancer Res. 1997<span class=GramE>;17:3137</span>3140. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9329620" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Ferrero-<span class=SpellE>Pous</span> M, <span
     class=SpellE>Hacene</span> K, <span class=SpellE>Bouchet</span> C, Le <span
     class=SpellE>Doussal</span> V, <span class=SpellE>Tubiana</span>-Hulin M, <span
     class=SpellE>Spyratos</span> F. Relationship between c-erbB-2 and other
     tumor characteristics in breast cancer prognosis. <span class=SpellE>Clin</span>
     Cancer Res. 2000<span class=GramE>;6:4745</span>4754. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11156229" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Bos</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> JL. <span class=SpellE><span class=GramE>ras</span></span>
     oncogenes in human cancer: a review. Cancer Res. 1989<span class=GramE>;49:4682</span>4689.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/2547513" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Clark GJ, Der CJ. <span class=SpellE>Ras</span>
     proto-oncogene activation in human malignancy. In: Markers CT, Garret T,
     Sell S, editor. Cellular Cancer. Totowa, NJ: Humana Press; 1995. pp.
     1752.</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Miyakis</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> S, <span class=SpellE>Sourvinos</span> G, <span
     class=SpellE>Spandidos</span> DA. Differential expression and mutation of
     the <span class=SpellE>ras</span> family genes in human breast cancer. <span
     class=SpellE>Biochem</span> <span class=SpellE>Biophys</span> Res <span
     class=SpellE>Commun</span>. 1998<span class=GramE>;251:609</span>612. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1006/bbrc.1998.9527.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/9792821" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1006%2Fbbrc.1998.9527" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Downward J. Targeting RAS <span class=SpellE>signalling</span>
     pathways in cancer therapy. Nat Rev Cancer. 2003<span class=GramE>;3:11</span>22.
     <span class=SpellE><span class=GramE>doi</span></span>: 10.1038/nrc969. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12509763" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1038%2Fnrc969" target="pmc_ext">Cross Ref</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>End DW, <span class=SpellE>Smets</span> G, Todd AV,
     Applegate TL, <span class=SpellE>Fuery</span> CJ, <span class=SpellE>Angibaud</span>
     P, <span class=SpellE>Venet</span> M, <span class=SpellE>Sanz</span> G, <span
     class=SpellE>Poignet</span> H, <span class=SpellE><span class=GramE>Skrzat</span></span>
     S, et al. Characterization of the antitumor effects of the selective
     farnesyl protein transferase inhibitor R115777 <i>in vivo</i> and <i>in
     vitro</i>. Cancer Res. 2001<span class=GramE>;61:131</span>137. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11196150" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Kelland</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> LR, Smith V, <span class=SpellE>Valenti</span> M,
     Patterson L, Clarke PA, <span class=SpellE>Detre</span> S, End D, Howes
     AJ, <span class=SpellE>Dowsett</span> M, Workman P, Johnston SR.
     Preclinical antitumor activity and <span class=SpellE>pharmacodynamic</span>
     studies with the farnesyl protein transferase inhibitor R115777 in human
     breast cancer. <span class=SpellE>Clin</span> Cancer Res. 2001<span
     class=GramE>;7:3544</span>3550. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11705875" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Moasser</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> MM, Rosen N. The use of molecular markers in
     farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast
     Cancer Res Treat. 2002<span class=GramE>;73:135</span>144. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1023/A:1015209123900.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12088116" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1023%2FA%3A1015209123900" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Malaney</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> S, Daly RJ. The <span class=SpellE>ras</span> <span
     class=SpellE>signalling</span> pathway in mammary tumorigenesis and
     metastasis. J Mammary Gland <span class=SpellE>Biol</span> Neoplasia. 2001<span
     class=GramE>;6:101</span>113. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1023/A:1009572700317. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11467446" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1023%2FA%3A1009572700317" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Grant S, <span class=SpellE>Qiao</span> L, Dent P.
     Roles of ERBB family receptor tyrosine kinases, and downstream signaling
     pathways, in the control of cell growth and survival. Front <span
     class=SpellE>Biosci</span>. 2002<span class=GramE>;7:d376</span>d389. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11815285" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>End DW. Farnesyl protein transferase inhibitors and
     other therapies targeting the <span class=SpellE>Ras</span> signal
     transduction pathway. Invest New Drugs. 1999<span class=GramE>;17:241</span>258.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1023/A:1006380320290. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10665477" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1023%2FA%3A1006380320290" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Lobell RB, Omer CA, Abrams MT, <span class=SpellE>Bhimnathwala</span>
     HG, <span class=SpellE>Brucker</span> MJ, <span class=SpellE>Buser</span>
     CA, <span class=SpellE>Davide</span> JP, <span class=SpellE>deSolms</span>
     SJ, <span class=SpellE>Dinsmore</span> CJ, Ellis-Hutchings MS, et al.
     Evaluation of <span class=SpellE>farnesyl:protein</span> transferase and <span
     class=SpellE>geranylgeranyl:protein</span> transferase inhibitor
     combinations in preclinical models. Cancer Res. 2001<span class=GramE>;61:8758</span>8768.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11751396" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Ohkanda</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> J, Knowles DB, <span class=SpellE>Blaskovich</span>
     MA, <span class=SpellE>Sebti</span> SM, Hamilton AD. Inhibitors of protein
     farnesyltransferase as novel anticancer agents. <span class=SpellE>Curr</span>
     Top Med Chem. 2002<span class=GramE>;2:303</span>323. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.2174/1568026023394281. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11944822" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.2174%2F1568026023394281" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Singh SB, <span class=SpellE>Lingham</span> RB.
     Current progress on farnesyl protein transferase inhibitors. <span
     class=SpellE>Curr</span> <span class=SpellE>Opin</span> Drug <span
     class=SpellE>Discov</span> <span class=SpellE>Devel</span>. 2002<span
     class=GramE>;5:225</span>244. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11926129" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Holland PA, Knox WF, <span class=SpellE>Potten</span>
     CS, Howell A, Anderson E, <span class=SpellE>Baildam</span> AD, <span
     class=SpellE>Bundred</span> NJ. Assessment of hormone dependence of <span
     class=SpellE>comedo</span> ductal carcinoma in situ of the breast. J Natl
     Cancer Inst. 1997<span class=GramE>;89:1059</span>1065. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1093/<span
     class=SpellE>jnci</span>/89.14.1059. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9230888" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1093%2Fjnci%2F89.14.1059" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Gandhi A, Holland PA, Knox WF, <span class=SpellE>Potten</span>
     CS, <span class=SpellE>Bundred</span> NJ. Effects of a pure antiestrogen on
     apoptosis and proliferation within human breast ductal carcinoma <i>in
     situ</i>. Cancer Res. 2000<span class=GramE>;60:4284</span>4288. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10945643" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>van de <span class=SpellE>Vijver</span> MJ, <span
     class=SpellE>Peterse</span> JL, <span class=SpellE>Mooi</span> WJ, <span
     class=SpellE>Wisman</span> P, <span class=SpellE>Lomans</span> J, <span
     class=SpellE>Dalesio</span> O, <span class=SpellE>Nusse</span> R. <span
     class=SpellE>Neu</span>-protein overexpression in breast cancer.
     Association with <span class=SpellE>comedo</span>-type ductal carcinoma in
     situ and limited prognostic value in stage II breast cancer. N <span
     class=SpellE>Engl</span> J Med. 1988<span class=GramE>;319:1239</span>1245.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/2903446" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Warnberg</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> F, <span class=SpellE>Nordgren</span>
     H, <span class=SpellE>Bergkvist</span> L, Holmberg L. <span class=SpellE>Tumour</span>
     markers in breast carcinoma correlate with grade rather than with
     invasiveness. Br J Cancer. 2001<span class=GramE>;85:869</span>874. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1054/bjoc.2001.1995.
     [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375068/">PMC free
     article</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11556839"
     target="pmc_ext">PubMed</a>] [<a
     href="http://dx.doi.org/10.1054%2Fbjoc.2001.1995" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Laidlaw IJ, Clarke RB, Howell A, Owen AW, <span
     class=SpellE>Potten</span> CS, Anderson E. The proliferation of normal
     human breast tissue implanted into <span class=SpellE>athymic</span> nude
     mice is stimulated by estrogen but not progesterone. Endocrinology. 1995<span
     class=GramE>;136:164</span>171. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1210/en.136.1.164. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/7828527"
     target="pmc_ext">PubMed</a>] [<a
     href="http://dx.doi.org/10.1210%2Fen.136.1.164" target="pmc_ext">Cross Ref</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Merritt AJ, Jones LS, <span class=SpellE>Potten</span>
     CS. Techniques in Apoptosis. London: Portland Press Ltd; 1996. pp. 269300.</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Harn</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> HJ, Shen KL, <span class=SpellE>Yueh</span> KC, Ho
     LI, Yu JC, Chiu SC, Lee WH. Apoptosis occurs more frequently in <span
     class=SpellE>intraductal</span> carcinoma than in infiltrating duct
     carcinoma of human breast cancer and correlates with altered p53
     expression: detected by terminal-<span class=SpellE>deoxynucleotidyl</span>-transferase-mediated
     <span class=SpellE>dUTP</span>-FITC nick end labelling (TUNEL)
     Histopathology. 1997<span class=GramE>;31:534</span>539. <span
     class=SpellE><span class=GramE>doi</span></span>:
     10.1046/j.1365-2559.1997.3270906.x. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9447384" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1046%2Fj.1365-2559.1997.3270906.x"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Moreno A, <span class=SpellE>Figueras</span> A, <span
     class=SpellE>Lloveras</span> B, Escobedo A, <span class=SpellE>Griera</span>
     E, Sierra A, <span class=SpellE>Fabra</span> A. Apoptosis in ductal
     carcinoma <i>in situ</i> of the breast. Breast J. 2001<span class=GramE>;7:245</span>248.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1046/j.1524-4741.2001.98116.x. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11678802" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1046%2Fj.1524-4741.2001.98116.x"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Bai M, <span class=SpellE>Agnantis</span> NJ, <span
     class=SpellE>Kamina</span> S, <span class=SpellE>Demou</span> A, <span
     class=SpellE>Zagorianakou</span> P, <span class=SpellE>Katsaraki</span> A,
     <span class=SpellE>Kanavaros</span> P. <i>In vivo</i> cell kinetics in
     breast carcinogenesis. Breast Cancer Res. 2001<span class=GramE>;3:276</span>283.
     <span class=SpellE><span class=GramE>doi</span></span>: 10.1186/bcr306. [<a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34112/">PMC free article</a>]
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11434879" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1186%2Fbcr306" target="pmc_ext">Cross Ref</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Zimmerman TM, <span class=SpellE>Harlin</span> H, <span
     class=SpellE>Odenike</span> OM, <span class=SpellE>Berk</span> S, Sprague
     E, <span class=SpellE>Karrison</span> T, Stock W, Larson RA, <span
     class=SpellE>Ratain</span> MJ, <span class=SpellE>Gajewski</span> TF.
     Dose-ranging <span class=SpellE>pharmacodynamic</span> study of <span
     class=SpellE>tipifarnib</span> (R115777) in patients with relapsed and
     refractory hematologic malignancies. J <span class=SpellE>Clin</span> <span
     class=SpellE>Oncol</span>. 2004<span class=GramE>;22:4816</span>4822. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1200/JCO.2004.03.200.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/15570084" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1200%2FJCO.2004.03.200" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Sepp-<span class=SpellE>Lorenzino</span> L, Ma Z, <span
     class=SpellE>Rands</span> E, Kohl NE, Gibbs JB, <span class=SpellE>Oliff</span>
     A, Rosen N. A <span class=SpellE>peptidomimetic</span> inhibitor of <span
     class=SpellE>farnesyl<span class=GramE>:protein</span></span> transferase
     blocks the anchorage-dependent and -independent growth of human tumor cell
     lines. Cancer Res. 1995<span class=GramE>;55:5302</span>5309. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/7585592" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Dy</span></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> GK, <span class=SpellE>Adjei</span> AA.
     Farnesyltransferase inhibitors in breast cancer therapy. Cancer Invest.
     2002<span class=GramE>;20</span>(<span class=SpellE>Suppl</span> 2):3037.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1081/CNV-120014884. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12442347" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1081%2FCNV-120014884" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>James G, Goldstein JL, Brown MS. Resistance of
     K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc
     Natl <span class=SpellE>Acad</span> <span class=SpellE>Sci</span> USA.
     1996<span class=GramE>;93:4454</span>4458. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1073/pnas.93.9.4454. [<a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC39559/">PMC free article</a>]
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8633088" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1073%2Fpnas.93.9.4454" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Whyte DB, <span class=SpellE>Kirschmeier</span> P, <span
     class=SpellE>Hockenberry</span> TN, Nunez-Oliva I, James L, <span
     class=SpellE>Catino</span> JJ, Bishop WR, <span class=SpellE>Pai</span>
     JK. K- and N-<span class=SpellE>Ras</span> are <span class=SpellE>geranylgeranylated</span>
     in cells treated with farnesyl protein transferase inhibitors. J <span
     class=SpellE>Biol</span> Chem. 1997<span class=GramE>;272:14459</span>14464.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1074/jbc.272.22.14459. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9162087" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1074%2Fjbc.272.22.14459" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Benz CC, Scott GK, <span class=SpellE>Sarup</span>
     JC, Johnson RM, <span class=SpellE>Tripathy</span> D, Coronado E, Shepard
     HM, Osborne CK. Estrogen-dependent, tamoxifen-resistant tumorigenic growth
     of MCF-7 cells transfected with HER2/<span class=SpellE>neu</span>. Breast
     Cancer Res Treat. 1993<span class=GramE>;24:85</span>95. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1007/BF01961241. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/8095168" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1007%2FBF01961241" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Zujewski</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> J, <span class=SpellE>Horak</span>
     ID, <span class=SpellE>Bol</span> CJ, <span class=SpellE>Woestenborghs</span>
     R, Bowden C, End DW, <span class=SpellE>Piotrovsky</span> VK, <span
     class=SpellE>Chiao</span> J, Belly RT, Todd A, et al. Phase I and
     pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in
     advanced cancer. J <span class=SpellE>Clin</span> <span class=SpellE>Oncol</span>.
     2000<span class=GramE>;18:927</span>941. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10673536" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Crul</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> M, de Klerk GJ, Swart M, <span class=SpellE>van't</span>
     Veer LJ, de Jong D, <span class=SpellE>Boerrigter</span> L, Palmer PA, <span
     class=SpellE>Bol</span> CJ, Tan H, de <span class=SpellE>Gast</span> GC,
     et al. <span class=GramE>Phase</span> I clinical and pharmacologic study
     of chronic oral administration of the farnesyl protein transferase
     inhibitor R115777 in advanced cancer. J <span class=SpellE>Clin</span> <span
     class=SpellE>Oncol</span>. 2002<span class=GramE>;20:2726</span>2735. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1200/JCO.2002.09.116.
     [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12039935" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1200%2FJCO.2002.09.116" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Johnston SR, <span class=SpellE>Hickish</span> T,
     Ellis P, Houston S, <span class=SpellE>Kelland</span> L, <span
     class=SpellE>Dowsett</span> M, Salter J, <span class=SpellE>Michiels</span>
     B, Perez-<span class=SpellE>Ruixo</span> JJ, Palmer P, et al. Phase II
     study of the efficacy and tolerability of two dosing regimens of the
     farnesyl transferase inhibitor, R115777, in advanced breast cancer. J <span
     class=SpellE>Clin</span> <span class=SpellE>Oncol</span>. 2003<span
     class=GramE>;21:2492</span>2499. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1200/JCO.2003.10.064. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12829668" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1200%2FJCO.2003.10.064" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Stanta</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> G, Bonin S, <span class=SpellE>Losi</span> L, <span
     class=SpellE>Eusebi</span> V. Molecular characterization of <span
     class=SpellE>intraductal</span> breast carcinomas. <span class=SpellE>Virchows</span>
     Arch. 1998<span class=GramE>;432:107</span>111. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1007/s004280050142. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9504854" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1007%2Fs004280050142" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Rundle A, Tang D, Brandt-Rauf P, Zhou J, Kelly A,
     Schnabel F, <span class=SpellE>Perera</span> FP. Association between the <span
     class=SpellE>ras</span> p21 <span class=SpellE>oncoprotein</span> in blood
     samples and breast cancer. Cancer Lett. 2002<span class=GramE>;185:71</span>78.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1016/S0304-3835(02)00236-7. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12142081" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1016%2FS0304-3835(02)00236-7"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Johnston SR, Head J, <span class=SpellE>Pancholi</span>
     S, <span class=SpellE>Detre</span> S, Martin LA, Smith IE, <span
     class=SpellE>Dowsett</span> M. Integration of signal transduction
     inhibitors with endocrine therapy: an approach to overcoming hormone
     resistance in breast cancer. <span class=SpellE>Clin</span> Cancer Res.
     2003<span class=GramE>;9:524S</span>32S. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12538510" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Kurokawa</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> H, <span class=SpellE>Lenferink</span>
     AE, Simpson JF, <span class=SpellE>Pisacane</span> PI, <span class=SpellE>Sliwkowski</span>
     MX, Forbes JT, Arteaga CL. Inhibition of HER2/<span class=SpellE>neu</span>
     (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action
     against HER2-overexpressing, tamoxifen-resistant breast cancer cells.
     Cancer Res. 2000<span class=GramE>;60:5887</span>5894. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11059787" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Gee JM, Harper ME, Hutcheson IR, Madden TA, Barrow
     D, <span class=SpellE>Knowlden</span> JM, McClelland RA, Jordan N, <span
     class=SpellE>Wakeling</span> AE, Nicholson RI. The <span class=SpellE>antiepidermal</span>
     growth factor receptor agent <span class=SpellE>gefitinib</span> (ZD1839/<span
     class=SpellE>Iressa</span>) improves <span class=SpellE>antihormone</span>
     response and prevents development of resistance in breast cancer <i>in
     vitro</i>. Endocrinology. 2003<span class=GramE>;144:5105</span>5117. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1210/en.2003-0705. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12960029" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1210%2Fen.2003-0705" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Schiff R, <span class=SpellE>Massarweh</span> S, <span
     class=SpellE>Shou</span> J, Osborne CK. Breast cancer endocrine
     resistance: how growth factor signaling and estrogen receptor <span
     class=SpellE>coregulators</span> modulate response. <span class=SpellE>Clin</span>
     Cancer Res. 2003<span class=GramE>;9:447S</span>454S. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12538499" target="pmc_ext">PubMed</a>]</span><span
     style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Appels NM, <span class=SpellE>Beijnen</span> JH, <span
     class=SpellE>Schellens</span> JH. Development of farnesyl transferase
     inhibitors: a review. Oncologist. 2005<span class=GramE>;10:565</span>578.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1634/theoncologist.10-8-565. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16177281" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1634%2Ftheoncologist.10-8-565"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Pan J, Yeung SC. Recent advances in understanding
     the antineoplastic mechanisms of farnesyltransferase inhibitors. Cancer
     Res. 2005<span class=GramE>;65:9109</span>9112. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1158/0008-5472.CAN-05-2635. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/16230362" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1158%2F0008-5472.CAN-05-2635"
     target="pmc_ext">Cross Ref</a>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l1 level1 lfo3;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Rhodes A, <span class=SpellE>Jasani</span> B,
     Couturier J, McKinley MJ, Morgan JM, Dodson AR, <span class=SpellE>Navabi</span>
     H, Miller KD, Balaton AJ. A formalin-fixed, paraffin-processed cell line
     standard for quality control of <span class=SpellE>immunohistochemical</span>
     assay of HER-2/<span class=SpellE>neu</span> expression in breast cancer.
     Am J <span class=SpellE>Clin</span> <span class=SpellE>Pathol</span>. 2002<span
     class=GramE>;117:81</span>89. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1309/4NCM-QJ9W-QM0J-6QJE. [<a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11789735" target="pmc_ext">PubMed</a>]
     [<a href="http://dx.doi.org/10.1309%2F4NCM-QJ9W-QM0J-6QJE" target="pmc_ext">Cross
     Ref</a>]</span><span style='mso-fareast-font-family:"Times New Roman"'><o:p></o:p></span></li>
</ol>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__abstractid1027759title">Abstract</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec5title">Introduction</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec6title">Materials
     and methods</a></span><span style='mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec18title">Results</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec22title">Discussion</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec23title">Conclusion</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec24title">Abbreviations</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec25title">Competing
     interests</a></span><span style='mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__sec26title">Authors'
     contributions</a></span><span style='mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l3 level1 lfo6;
     display:none;tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     display:none;mso-hide:all;mso-ansi-language:EN'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557711/?report=classic#__ref-listid939199title">References</a></span><span
     style='mso-fareast-font-family:"Times New Roman";display:none;mso-hide:
     all'><o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span lang=EN style='font-size:12.0pt;
font-family:"Arial","sans-serif";mso-ansi-language:EN'>Articles from Breast
Cancer <span class=GramE>Research :</span> BCR are provided here courtesy of <span
class=SpellE><b>BioMed</b></span><b> Central</b></span></p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
